Tearful relationships? Sex, hormones, the lacrimal gland, and aqueous-deficient dry eye

Ocular Surface

Volumn 2, Issue 2, 2004, Pages 92-123

  Sullivan, David A ^a  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

Androgens; Dry eye; Endocrine system; Estrogen; Hormones; Progesterone; Sex hormones; Sjogren syndrome; Steroids

Indexed keywords

8 BROMO CYCLIC AMP; ALPHA INTERMEDIN; ANDROGEN; ANDROGEN BINDING PROTEIN; ANDROGEN RECEPTOR; ARGIPRESSIN; CARBACHOL; CHOLECYSTOKININ; CHORIONIC GONADOTROPIN; CORTICOTROPIN; CYPROTERONE ACETATE; ESTROGEN DERIVATIVE; FOLLITROPIN; GLUCAGON; GLUCOCORTICOID; GROWTH HORMONE; HORMONE DERIVATIVE; INSULIN; ISOBUTYLMETHYLXANTHINE; ISOPRENALINE; LUTEINIZING HORMONE; MELATONIN; MINERALOCORTICOID; OXYTOCIN; PARATHYROID HORMONE; PROLACTIN; RETINOIC ACID; THYROTROPIN; THYROXINE; UNINDEXED DRUG;

ANDROGEN DEFICIENCY; DRUG RECEPTOR BINDING; DRY EYE; ENDOCRINE SYSTEM; HORMONE ACTION; HUMAN; HYPOPHYSECTOMY; LACRIMAL GLAND DISEASE; LACRIMAL GLAND FUNCTION; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; REVIEW; SEX DIFFERENCE; SJOEGREN SYNDROME; TEAR FILM;

EID: 20144365575     PISSN: 15420124     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1542-0124(12)70147-7     Document Type: Review

References (553)

1. Caffery BE, Richter D, Simpson T, et al. CANDEES: The Canadian dry eye epidemiology study. Adv Exp Med Biol 1998;438:805-6
2. McCarty CA, Bansal AK, Livingston PM, et al. The epidemiology of dry eye in Melbourne, Australia. Ophthalmology 1998;105:1114-9
3. PharMetrics/NDC Health Information Services. Prevalence and treatment of dry eye in a managed care population. Draft Report 2000
4. Schaumberg DA, Sullivan DA, Dana MR. Epidemiology of dry eye syndrome. Adv Exp Med Biol 2002;506:989-98
5. Albietz JM. Prevalence of dry eye subtypes in clinical optometry practice. Optom Vis Sci 2000;77:357-63
6. Versura P, Profazio V, Cellini M, et al. Eye discomfort and air pollution. Ophthalmologica 1999;213:103-9
7. Schaumberg DA, Sullivan DA, Buring JE, Dana MR. Prevalence of dry eye syndrome among US women. Am J Ophthalmol 2003;136:318-26
8. Chia EM, Mitchell P, Rochtchina E, et al. Prevalence and associations of dry eye syndrome in an older population: the Blue Mountains Eye Study. Clin Exp Ophthalmol 2003;31:229-32
9. Lin PY, Tsai SY, Cheng CY, et al. Prevalence of dry eye among an elderly Chinese population in Taiwan: the Shihpai Eye Study. Ophthalmology 2003;110:1096-101
10. Caffery B, Richter D, Simpson T, et al. The prevalence of dry eye in contact lens wearers: Part 2 of the Canadian dry eye epidemiology study (CANDEES) (abstract). Invest Ophthalmol Vis Sci 1996;37(suppl):S72
11. Berger E, Loewy R. Ocular troubles originating from the female genital tract, in Alcan F (ed). Paris, Ancienne Libraire Germer Balliere et Cie, 1905
12. Kollock CW. Diseases and functional disorders of the eye, produced by normal and abnormal conditions of the sexual organs. Trans S Carolina Med Assoc 1888;97-102
13. Alsbirk PH. Corneal diameter in Greenland Eskimos. Anthropometric and genetic studies with special reference to primary angle-closure glaucoma. Acta Ophthalmol (Copenh) 1975;53:635-46
14. Sullivan DA, Wickham LA, Krenzer KL, et al. Aqueous tear deficiency in Sjögren's syndrome: Possible causes and potential treatment, in Pleyer U, Hartmann C, Sterry W (eds). Oculodermal diseases - immunology of bullous oculo-mucocutaneous disorders. Buren, The Netherlands, Aeolus Press, 1997, pp 95-152
15. Haffner SM, Klein R, Dunn JF, et al. Increased testosterone in Type I diabetics with severe retinopathy. Ophthalmology 1990;97:1270-4
16. Klein BE. Lens opacities in women in Beaver Dam, Wisconsin: is there evidence of an effect of sex hormones? Trans Am Ophthalmol Soc 1994;517-41
17. Kuscu NK, Toprak AB, Vatansever S, et al. Tear function changes of postmenopausal women in response to hormone replacement therapy. Maturitas 2003;44:63-8
18. Cavallero C. Relative effectiveness of various steroids in an androgen assay using the exorbital lacrimal gland of the castrated rat. Acta Endocrinol (Copenh) 1967;55:119-30
19. Guyer DR, Gragoudas ES. Idiopathic macular holes, in Albert DM, Jakobiec FA(eds). Principles and practice of ophthalmology: Basic sciences, Vol 2. Philadelphia, WB Saunders, 1994, pp 883-9
20. Hitawari S. Protein anabolic steroids in ophthalmology. Ber dtsch ophthal Ges 1963;65:424-6
21. Wickham LA, Gao J, Toda I, et al. Identification of androgen, estrogen and progesterone receptor mRNAs in the eye. Acta Ophthalmol 2000;78:146-53
22. Rocha EM, Wickham LA, Silveira LA, et al. Identification of androgen receptor protein and 5α-reductase mRNA in human ocular tissues. Br J Ophthalmol 2000;84:76-84
23. Schumacher H, Machemer R. Experimental investigations on the treatment of cortisone lesions of the cornea. Klin Monatsbl Augenheilkd 1966;148:121-6
24. Knepper PA, Collins JA, Frederick R. Effect of dexamethasone, progesterone, and testosterone on IOP and GAGs in the rabbit eye. Invest Ophthalmol Vis Sci 1985;26:1093-100
25. Knepper PA. Method for the prevention of ocular hypertension, treatment of glaucoma and treatment of ocular hypertension. US Patent 4,617,299.
26. Bonini S, Lambiase A, Schiavone M, et al. Estrogen and progesterone receptors in vernal keratoconjunctivitis. Ophthalmology 1995;102:1374-9
27. Imafidon CO, Imafidon JE. Contact lenses in pregnancy. Br J Obstet Gynecol 1992;99:865-8
28. Richardson PSR, Nichols C, Parsons MA, Rennie IG. Sex steroid hormone receptors in the human retina and choroid; an immunocytochemical study (abstract). Invest Ophthalmol Vis Sci 1995;36 (suppl):S128
29. Hollwich F, Verbeck B. Side-effects of oral contraceptives on the eye. Germ med Mth 1970;XV:155-9
30. Imafidon C, Akingbade A, Imafidon J, Onwudiegwu U. Anterior segment adaptations in gestation. Optom Today, April 5, 1993
31. Serrander A-M, Peek KE. Changes in contact lens comfort related to the menstrual cycle and menopause. A review of articles. J Am Optom Assoc 1993;64:162-6
32. Guttridge NM. Changes in ocular and visual variables during the menstrual cycle. Ophthal Physiol Opt 1994;14:38-48
33. Moore CP, Wilsman NJ, Nordheim EV, et al. Density and distribution of canine conjunctival goblet cells. Invest Ophthalmol Vis Sci 1987;28:1925-32
34. Tsai TH, Scheving LE, Scheving LA, Pauly JE. Sex differences in circadian rhythms of several variables in lymphoreticular organs, liver, kidney, and corneal epithelium in adult CD2F1 mice. Anat Rec 1985;211:263-70
35. Kramer P, Lubkin V, Potter W, et al. Cyclic changes in conjunctival smears from menstruating females. Ophthalmology 1990;97:303-7
36. Waltman SR, Burde RM, Berrios J. Prevention of corneal homograft rejection by estrogens. Transplantation 1971;11:194-6
37. Guggenmoos-Holzmann I, Engel B, Henke V, Naumann GOH. Cell density of human lens epithelium in women higher than in men. Invest Ophthalmol Vis Sci 1989;30:330-2
38. Saruya S. Studies on allergic conjunctivitis. Effects of castration and sex hormone administration on experimental allergic conjunctivitis. Nippon Ganka Gakkai Zasshi 1968;72:833-45
39. Zeligs MA, Gordon K. Dehydroepiandrosterone therapy for the treatment of dry eye disorders. Int Patent Application WO 94/04155, March, 1994
40. Mircheff AK. Understanding the causes of lacrimal insufficiency: implications for treatment and prevention of dry eye syndrome, in Research to Prevent Blindness Science Writers Seminar. New York, Research to Prevent Blindness, 1993:51-4
41. Davidson SI. Reported adverse effects of oral contraceptives on the eye. Trans Ophthalmol Soc UK 1971;91:561-74
42. Cornell-Bell AH, Sullivan DA, Allansmith MR. Gender-related differences in the morphology of the lacrimal gland. Invest Ophthalmol Vis Sci 1985;26:1170-5
43. Richards SM, Schirra F, Yamagami H, et al. Sex-related differences in gene expression in the mouse meibomian gland (abstract). ARVO e-abstract #2520, 2003 (www.arvo.org)
44. Jones AL, Carrington L, Albon J, et al. Localisation of receptors to estradiol, progesterone and androgen in the bovine cornea (abstract). ARVO e-abstract #915, 2003 (www.arvo.org)
45. Tanemura M, Miyamoto N, Mandai M, et al. Estrogen may enhance laser-induced CNV formation by enhancing VEGFR2 gene expression (abstract). ARVO e-abstract #548, 2003 (www.arvo.org)
46. Stern M. Ocular surface inflammation: a causative factor in dry eye (abstract). J Rheumatol 1997;50 (suppl):42
47. Chew CK, Hykin PG, Janswijer C, et al. The casual level of meibomian lipids in humans. Curr Eye Res 1993;12:255-9
48. Cobelli S, Dambrosio M, Farina G, et al. Long term toxicity in adjuvant treatment with tamoxifen. J Chemother 1997;9:300-3
49. Kahn HA, Leibowitz HM, Ganley JP, et al. The Framingham Eye Study. I. Outline and major prevalence findings. Am J Epidemiol 1977;106:17-32
50. Hiller R, Sperduto RD, Ederer F. Epidemiologic associations with nuclear, cortical, and posterior subscapular cataracts. Am J Epidemiol 1986;124:916-25
51. Ruben M. Contact lenses and oral contraceptives. Br Med J 1966;1:1110
52. Harding JJ, Rixon KC, Marriott FH. Men have heavier lenses than women of the same age. Exp Eye Res 1977;26:651
53. Norn MS. Desiccation of the precorneal tear film. I. Corneal wetting time. Acta Ophthalmol 1969;47:865-80
54. Klein R, Klein BE, Linton KLP, DeMets DL. The Beaver Dam Eye Study: Visual acuity. Ophthalmology 1991;98:1310-5
55. Klein R, Klein BE, Linton KLP. Prevalence of age-related maculopathy. The Beaver Dam Eye Study Ophthalmology 1992;99:933-43
56. Klein R, Klein BE, Moss SE, et al. The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1984;102:520-6
57. Kambert BW. The effects of progestins and estrogens on the permeability of the lens. Arch Ophthalmol 1968;80:230-34
58. Millodot M, Lamont A. Influence of menstruation on corneal sensitivity. Br J Ophthalmol 1974;58:752-6
59. Williamson JR, Chang K, Tilton RG, et al. Increased vascular permeability in spontaneously diabetic BB/W rats and in rats with mild versus severe streptozotocin-induced diabetes. Prevention by aldose reductase inhibitors and castration. Diabetes 1987;36:813-21
60. Qureshi IA. Intraocular pressure: a comparative analysis in two sexes. Clin Physiol 1997;17:247-55
61. Salyer DL, Lund TD, Fleming DE, Lephart ED, Horvath TL. Sexual dimorphism and aromatase in the rat retina. Brain Res Dev Brain Res 2001;126:131-6
62. Sullivan DA, Sullivan BD, Ullman MD, et al. Androgen influence on the meibomian gland. Invest Ophthalmol Vis Sci 2000;41:3732-42
63. Krenzer KL, Dana MR, Ullman MD, et al. Effect of androgen deficiency on the human meibomian gland and ocular surface. J Clin Endocrinol Metab 2000;85:4874-82
64. Sullivan BD, Evans JE, Krenzer KL, et al. Impact of anti-androgen treatment on the fatty acid profile of neutral lipids in human meibomian gland secretions. J Clin Endocrinol Metab 2000;85:4866-73
65. 45Ca in rats after administration of a single dose of estrogens during the first days of postnatal life. Albrecht Von Graefes Arch Klin Exp Ophthalmol 1974;191:85-91
66. Jacobs M, Buxton D, Kramer P, et al. The effect of oophorectomy on the rabbit lacrimal system (abstract). Invest Ophthalmol Vis Sci Suppl 1986;27 (suppl):25
67. Ploc I, Sulcova J, Starka L. Androgen uptake in the epithelium of the bovine cornea. Ophthalmic Res 1978;10:16-21
68. Hildebrandt PG. Erfahrungen mit einer lokalen anabolen Therapie bei Hornhauterkrankungen. Med Mschr 1974;8:359-60
69. Yamamoto T, Terada N, Nishizawa Y, Petrow V. Angiostatic activities of medroxyprogesterone acetate and its analogues. Int J Cancer 1994;56:393-9
70. Sullivan BD, Evans JE, Dana MR, Sullivan DA. Impact of androgen deficiency on the lipid profiles in human meibomian gland secretions. Adv Exp Med Biol 2002;506:449-58
71. Yamagami H, Richards SM, Sullivan BD, et al. Gender-associated differences in gene expression of the meibomian gland. Adv Exp Med Biol 2002;506:459-64
72. Yamagami H, Schirra F, Liu M, et al. Androgen influence on gene expression in the meibomian gland. Adv Exp Med Biol 2002;506:477-82
73. Suzuki T, Sullivan BD, Liu M, et al. Estrogen and progesterone effects on the morphology of the mouse meibomian gland. Adv Exp Med Biol 2002;506:483-8
74. Schaumberg DA, Buring JE, Sullivan DA, Dana MR. Hormone replacement therapy and the prevalence of dry eye syndrome. JAMA 2001;286:2114-9
75. Esmaeli B, Harvey JT, Hewlett B. Immunohistochemical evidence for estrogen receptors in meibomian glands. Ophthalmology 2000;107:180-4
76. Moss SE, Klein R, Klein BE. Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol 2000;118:1264-8
77. Connor CG, Flockencier LL, Hall CW. The influence of gender on the ocular surface. J Am Optom Assoc 1999;70:182-6
78. Cheung SW, Cho P, Douthwaite W. Corneal shape of Hong Kong-Chinese. Ophthalmic Physiol Opt 2000;20:119-5
79. Saha P, Yang JJ, Lee VH. Existence of a p-glycoprotein drug efflux pump in cultured rabbit conjunctival epithelial cells. Invest Ophthalmol Vis Sci 1998;39:1221-6
80. Vavilis D, Maloutas S, Nasioutziki M, et al. Conjunctiva is an estrogen-sensitive epithelium. Acta Obstet Gynecol Scand 1995;74:799-802
81. Suzuki T, Kinoshita Y, Tachibana M, et al. Expression of sex steroid hormone receptors in human cornea. Curr Eye Res 2001;22:28-33
82. Cho P, Lam C. Factors affecting the central corneal thickness of Hong Kong-Chinese. Curr Eye Res 1999;18:368-74
83. Sator MO, Joura EA, Golaszewski T, et al. Treatment of menopausal keratoconjunctivitis sicca with topical oestradiol. Br J Obstet Gynaecol 1998;105:100-2
84. Gilger BC, Whitley RD, McLaughlin SA, et al. Canine corneal thickness measured by ultrasonic pachymetry. Am J Vet Res 1991;52:1570-2
85. Aupperlee MD, Wertz JT, Ingersoll KE, Ubels JL. Identification of androgen receptors in rabbit lacrimal gland by immunohistochemistry. Adv Exp Med Biol 2002;506:137-41
86. Hadeyama T, Nakayasu K, Ha NT, Nakamura S. Expression of estrogen receptors α and β, androgen receptors and progesterone receptors in human cornea. Nippon Ganka Gakkai Zasshi 2002; 106:557-64
87. Pokharel GP, Negrel AD, Munoz SR, Ellwein LB. Refractive error study in children: results from Mechi Zone, Nepal. Am J Ophthalmol 2000;129:436-44
88. Lam BL, Lee DJ, Gomez-Marin O. Prevalence of usual-corrected binocular distance visual acuity impairment in Hispanic and non-Hispanic adults. Ophthalmic Epidemiol 2000;7:73-83
89. Tachibana M, Kobayashi Y, Kasukabe T, et al. Expression of androgen receptor in mouse eye tissues. Invest Ophthalmol Vis Sci 2000;41:64-6
90. Tachibana M, Kasukabe T, Kobayashi Y, et al. Expression of estrogen receptor α and β in the mouse cornea. Invest Ophthalmol Vis Sci 2000;41:668-70
91. Sorrentino C, Affinito P, Mattace Raso F, et al. [Effect of hormone replacement therapy on postmenopausal ocular function.] Minerva Ginecol 1998;50:19-24
92. Uchida M, Tsuboi H, Yamaji T, et al. Oikawa T. Inhibition by 9αfluoromedoroxyprogesterone acetate (FMPA) against mammary carcinoma induced by dimethylbenz[a]anthracene in rats and angiogenesis in the rabbit cornea - comparison with medroxyprogesterone acetate (MPA). Cancer Lett 2000;154:63-9
93. Yamaji T, Tsuboi H, Murata N, et al. Anti-angiogenic activity of a novel synthetic agent, 9 α-fluoromedroxyprogesterone acetate. Cancer Lett 1999;145:107-14
94. Benitez del Castillo JM, del Rio T, Garcia-Sanchez J. Effects of estrogen use on lens transmittance in postmenopausal women. Ophthalmology 1997;104:970-3
95. Gierek A, Sosnierz M, Bialas B, Szaflik J. Influence of estrogens on intraocular tension in the eyeballs of rabbits. Ophthalmologica 1976;172:400-10
96. Campuzano Arguello M, Juarez Echenique JC, Lopez Perez G, et al. Allergens and risk factors in pediatric patients with allergic seasonal conjunctivitis. Rev Alerg Mex 2002;49:105-11
97. Albietz JM, Lenton LM, McLennan SG. Effect of laser in situ keratomileusis for hyperopia on tear film and ocular surface. J Refract Surg 2002;18:113-23
98. Rudnicka AR, Frost C, Owen CG, Edgar DF. Nonlinear behavior of certain optic nerve head parameters and their determinants in normal subjects. Ophthalmology 2001;08:2358-68
99. Bonini S, Bonini S, Lambiase A, et al. Vernal keratoconjunctivitis revisited: a case series of 195 patients with long-term followup. Ophthalmology 2000;107:1157-63
100. Lomholt JA, Ehlers N. Graft survival and risk factors of penetrating keratoplasty for microbial keratitis. Acta Ophthalmol Scand 1997;75:418-22
101. Zurawski CA, McCarey BE, van Rij G, Fernandes A. Corneal biometrics of the rhesus monkey (Macaca mulatta). J Med Primatol 1989;18:461-6
102. Leach NE, Wallis NE, Lothringer LL, Olson JA. Corneal hydration changes during the normal menstrual cycle - a preliminary study. J Reprod Med 1971;6:201-4
103. Soni PS. Effects of oral contraceptive steroids on the thickness of human cornea. Am J Optom Physiol Opt 1980;57:825-34
104. Riss B, Binder S, Riss P, Kemeter P. Corneal sensitivity during the menstrual cycle. Br J Ophthalmol 1982;66:123-6
105. Kiely PM, Carney LG, Smith G. Menstrual cycle variations of corneal topography and thickness. Am J Optom Physiol Opt 1983;60:822-9
106. Suzuki T, Sullivan DA. Estrogen stimulation of cytokine gene expression in human corneal epithelial cells (abstract). ARVO e-abstract #90, 2002 (www.arvo.org)
107. Suzuki T, Sullivan DA. Estrogen-induced increase of matrix metalloproteinase mRNA levels in human corneal epithelial cells. ARVO e-abstract #1027, 2003 (www.arvo.org)
108. Ubels JL, Wertz JT, Ingersoll KE, et al Down-regulation of androgen receptor expression and inhibition of lacrimal gland cell proliferation by retinoic acid. Exp Eye Res 2002;75:561-71
109. Verbeck B. [Ocular and metabolic findings in patients on oral contraceptives]. Klin Monatsbl Augenheilkd 1973;162:612-21
110. Yazici B, Hammad AM, Meyer DR Lacrimal sac dacryoliths: predictive factors and clinical characteristics. Ophthalmology 2001;108:1308-12
111. Madia F, Liberati V, de Feo G, Marcozzi G. Variations of lacrimal fluid peroxidase activity in female and male rats. Ophthalmic Res 2001;33:176-9
112. Liberati V, de Feo G, Madia F, Marcozzi G. Effect of oral contraceptives on lacrimal fluid peroxidase activity in women. Ophthalmic Res 2002;34:251-3
113. Luo F, Zhang H, Sun X. The change of tear secretion and tear film stability in castrated male rabbits. Chung Hua Yen Ko Tsa Chih 2001;37:458-61
114. Tachibana M, Adachi W, Kinoshita S, et al. Androgen-dependent hereditary mouse keratoconus: linkage to an MHC region. Invest Ophthalmol Vis Sci 2002;43:51-7
115. Okada M, Ogasawara A, Sekine K, et al. Antiangiogenic and antimetastatic effects of toremifene citrate. Gan To Kagaku Ryoho 2001;28:1099-1104
116. Blackwell KL, Haroon ZA, Shan S, et al. Tamoxifen inhibits angiogenesis in estrogen receptor-negative animal models. Clin Cancer Res 2000;6:4359-64
117. Fuchsjager-Mayrl G, Nepp J, Schneeberger C, et al. Identification of estrogen and progesterone receptor mRNA expression in the conjunctiva of premenopausal women. Invest Ophthalmol Vis Sci 2002;43:2841-4
118. Okon A, Jurowski P, Gos R. The influence of the hormonal replacement therapy on conjunctival epithelium morphology among peri- and postmenopausal women. Klin Oczna 2001;103:183-6
119. Vavilis D, Agorastos T, Vakiani M, et al. The effect of transdermal estradiol on the conjunctiva in postmenopausal women. Eur J Obstet Gynecol Reprod Biol 1997;72:93-6
120. Lund TD, Fleming DE, Dayton JR, et al. Dietary soy phytoestrogens effects on retinal thickness in rats.
121. Cascio C, Guarneri R, Russo D, et al. A caspase-3-dependent pathway is predominantly activated by the excitotoxin pregnenolone sulfate and requires early and late cytochrome c release and cell-specific caspase-2 activation in the retinal cell death. J Neurochem 2002;83:1358-71
122. Munaut C, Lambert V, Noel A, et al. Presence of oestrogen receptor type β in human retina. Br J Ophthalmol 2001;85:877-82
123. Nonaka A, Kiryu J, Tsujikawa A, et al. Administration of 17β-estradiol attenuates retinal ischemia-reperfusion injury in rats. Invest Ophthalmol Vis Sci 2000;41:2689-96
124. Ogueta SB, Schwartz SD, Yamashita CK, Farber DB. Estrogen receptor in the human eye: influence of gender and age on gene expression. Invest Ophthalmol Vis Sci 1999;40:1906-11
125. Kobayashi K, Kobayashi H, Ueda M, Honda Y. Estrogen receptor expression in bovine and rat retinas. Invest Ophthalmol Vis Sci 1998;39:2105-10
126. Cousins SW, Marin-Castano ME, Espinosa-Heidmann DG, et al. Female gender, estrogen loss, and Sub-RPE deposit formation in aged mice. Invest Ophthalmol Vis Sci 2003;44:1221-9
127. Marin-Castano ME, Elliot SJ, Potier M, et al. Regulation of estrogen receptors and MMP-2 expression by estrogens in human retinal pigment epithelium. Invest Ophthalmol Vis Sci 2003;44:50-9
128. Younan C, Mitchell P, Cumming RG, et al. Hormone replacement therapy, reproductive factors, and the incidence of cataract and cataract surgery: The Blue Mountains Eye Study. Am J Epidemiol 2002;155:997-1006
129. Freeman EE, Munoz B, Schein OD, West SK. Hormone replacement therapy and lens opacities: The Salisbury Eye Evaluation project. Arch Ophthalmol 2001;119:1687-92
130. Worzala K, Hiller R, Sperduto RD, et al. Postmenopausal estrogen use, type of menopause, and lens opacities: the Framingham studies. Arch Intern Med 2001;161:1448-54
131. Sone H, Okuda Y, Kawakami Y, et a;. Progesterone induces vascular endothelial growth factor on retinal pigment epithelial cells in culture. Life Sci 1996;59:21-5
132. Macaione S, Ientile R, Lentini M, Di Giorgio RM. Effects of estrogens and progesterone on GABA system in ovariectomized rat retina. Ital J Biochem 1981;30:279-89
133. Azzarolo AM, Mircheff AK, Kaswan RL, et al. Androgen support of lacrimal gland function. Endocrine 1997;6:39-45
134. Cenedella RJ, Sexton PS, Zhu XL. Lens epithelia contain a high-affinity membrane steroid hormone-binding protein. Invest Ophthalmol Vis Sci 1999;40:1452-9
135. Christ T, Marquardt R, Stodtmeister R, Pillunat LE. Modification of tear film break-up time by hormonal contraceptives. Fortschr Ophthalmol 1986;83:108-11
136. Midelfart A. Women and men - same eyes? Acta Ophthalmol Scand 1996;74:589-92
137. Chizek DJ, Franceschetti AT. Oral contraceptives: their side effects and ophthalmological manifestations. Surv Ophthalmol 1969;14:90-105
138. Decherney AH. The use of birth control pills in women with medical disorders. Clin Obstet Gynecol 1981;24:965-75
139. Yolton DP, Yolton RL, Lopez R, et al. The effects of gender and birth control pill use on spontaneous blink rates. J Am Optom Assoc 1994;65:763-70
140. Ziai N, Ory SJ, Khan AR, Brubaker RF. β-human chorionic gonadotropin, progesterone, and aqueous dynamics during pregnancy. Arch Ophthalmol 1994;112:801-6
141. Phillips K, Arffa R, Cintron C, et al. Effects of prednisolone and medroxyprogesterone on corneal wound healing, ulceration, and neovascularization. Arch Ophthalmol 1983;101:640-3
142. Crabb CV. Endocrine influences on ulceration and regeneration in the alkali-burned cornea. Arch Ophthalmol 1977;95:1866-70
143. Newsome NA, Gross J. Prevention by medroxyprogesterone of perforation in the alkali-burned rabbit cornea: inhibition of collagenolytic activity. Invest Ophthalmol Vis Sci 1977;16:21-31
144. Lass JH, Berman MB, Campbell RC, et al. Treatment of experimental herpetic interstitial keratitis with medroxyprogesterone. Arch Ophthalmol 1980;98:520-7
145. Krenzer KL, Cermak JM, Tolls DB, et al. Comparative signs and symptoms of dry eye in primary and secondary Sjogren's syndrome and meibomian gland disease (abstract). Invest Ophthalmol Vis Sci 1990;40(suppl):S2864
146. Nabata H, Horiuchi H, Miyata K, et al. Histopathological study of the human meibomian glands (abstract). Invest Ophthalmol Vis Sci 1994;35(suppl):1789
147. Hykin PG, Bron AJ. Age-related morphological changes in lid margin and meibomian gland anatomy. Cornea 1992;11:334-42
148. Fox RI (ed). Sjogren's syndrome. Rheum Dis Clin North Am 1992;18
149. Talal N, Moutsopoulos HM, Kassan SS (eds). Sjogren's syndrome. clinical and immunological aspects. Berlin,Springer Verlag, 1987
150. Homma M, Sugai S, Tojo T (eds). Sjogren's syndrome. state of the art. Amsterdam, Kugler Press, 1994
151. McCarthy M. The "gender" gap in autoimmune disease. Lancet 2000;356:1088
152. Saito I, Terauchi K, Shimuta M, et al. Expression of cell adhesion molecules in the salivary and lacrimal glands of Sjogren's syndrome. J Clin Lab Anal 1993;7:180-7
153. Rocha EM, Wickham LA, Huang Z, et al. Presence and testosterone influence on the levels of anti- and pro-inflammatory cytokines in lacrimal tissues of a mouse model of Sjogren's syndrome. Adv Exp Med Biol 1998;438:485-91
154. Toda I, Wickham LA, Sullivan DA. Gender and androgen treatment influences the expression of proto-oncogenes and apoptotic factors in lacrimal and salivary tissues of MRL/lpr mice. Clin Immunol Immunopath 1998;86:59-71
155. Toda I, Sullivan BD, Wickham LA, Sullivan DA. Gender and androgen-related influence on the expression of proto-oncogene and apoptotic factor mRNAs in lacrimal glands of autoinumme and non-autoimmune mice. J Steroid Biochem Mol Biol 1999;71:49-61
156. Sullivan DA. Sex hormones and Sjogren's syndrome. J Rheumatol 1997;24 (Suppl 50):17-32
157. Toda I, Sullivan BD, Rocha EM, et al. Impact of gender on exocrine gland inflammation in mouse models of Sjogrens syndrome. Exp Eye Res 1999;69:355-66
158. Tornwall J, Lane TE, Fox RI, Fox HS. T cell attractant chemokine expression initiates lacrimal gland destruction in nonobese diabetic mice. Lab Invest 1999;79:1719-26
159. Bacman SR, Berra A, Sterin-Borda L, Borda ES. Human primary Sjogren's syndrome autoantibodies as mediators of nitric oxide release coupled to lacrimal gland muscarinic acetylcholine receptors. Curr Eye Res 1998;17:1135-42
160. Robinson CP, Cornelius J, Bounous DE, et al. Characterization of the changing lymphocyte populations and cytokine expression in the exocrine tissues of autoinumme NOD mice. Autoimmunity 1998;27:29-44
161. Bacman S, Perez Leiros C, Sterin-Borda L, et al. Autoantibodies against lacrimal gland M3 muscarinic acetylcholine receptors in patients with primary Sjogren's syndrome. Invest Ophthalmol Vis Sci 1998;39:151-6
162. Zoukhri D, Hodges RR, Byon D, Kublin CL. Role of proinflammatory cytokines in the impaired lacrimation associated with autoimmune xerophthalmia. Invest Ophthalmol Vis Sci 2002;43:1429-36
163. Zoukhri D, Kublin CL. Impaired neurotransmitter release from lacrimal and salivary gland nerves of a murine model of Sjogren's syndrome. Invest Ophthalmol Vis Sci 2001;42:925-32
164. Konno A, Takada K, Saegusa J, Takiguchi M. Presence of B7-2+ dendritic cells and expression of Th1 cytokines in the early development of sialodacryoadenitis in the IqI/Jic mouse model of primary Sjogren's syndrome. Autoimmunity 2003;36:247-54
165. Tsubota K, Fujita H, Tadano K, et al. Abnormal expression and function of Fas ligand of lacrimal glands and peripheral blood in Sjogren's syndrome patients with enlarged exocrine glands. Clin Exp Immunol 2002;129:177-82
166. Ogawa Y, Kuwana M, Yamazaki K, et al. Periductal area as the primary site for T-cell activation in lacrimal gland chronic graft-versus-host disease. Invest Ophthalmol Vis Sci 2003;44:1888-96
167. Tier H. Über Zellteilung und Kernklassenbildung in der Glandula orbitalis exterria der Ratte. Acta path microbiol scand Suppl. 1944;50:1-185.
168. Gabe M. Conditionnement hormonal de la morphologie des glandes sus-parotidiennes chez le Rat albinos. Compt rend Séanc Soc Biol 1955;149:223-5
169. Parhon CI, Babes A, Petrea I, et al. Structura si Dimorfismul sexual al glandelor parotide la Sobolanul Alb. Bul Stiint Sect de St, nte med 1955;7:3
170. Calmettes L, Déodati F, Planel H, Bec P. Influence des hormones génitales sur la glande lacrymale. Bull Soc Fr Ophtalmol 1956;69:263-70
171. Walker R. Age changes in the rat's exorbital lacrimal gland. Anat Rec 1958;132:49-69
172. Baquiche M. Le dimorphisme sexuel de la glande de Loewenthal chez le rat albinos. Acta Anat 1959;36:247-80
173. Ducommun P, Ducommun S, Baquiche M. Comparaison entre l'action du 17-ethyl-19-nor-testosterone et du propionate de testosterone chez le rat adulte et immature. Acta Endocrin 1959;30:78-92
174. Waterhouse JP. Focal adenitis in salivary and lacrimal glands. Proc R Soc Med 1963;56:911-8
175. Luciano L. Die feinstruktur der tränendrüse der ratte und ihr geschlechtsdimorphismus. Zeitschrift für Zellforschung 1967;76:1-20
176. Hahn JD. Effect of cyproterone acetate on sexual dimorphism of the exorbital lacrimal gland in rats. J Endocrinol 1969;45:421-5
177. Paulini K, Beneke G, Kulka R. Age- and sex-dependent changes in glandular cells. I. Histologic and chemical investigations on the glandular lacrimalis, glandular intraorbitalis, and glandula orbitalis external of the rat. Gerontologia 1972;18:131-46
178. Paulini K, Mohr W, Beneke G, Kulka R. Age- and sex-dependent changes in glandular cells. II. Cytomorphometric and autoradiographic investigations on the glandular lacrimalis, glandular intraorbitalis, and glandula orbitalis external of the rat. Gerontologia 1972;18:147-56
179. Lauria A, Porcelli F. Leucine aminopeptidase (LAP) activity and sexual dimorphism in rat exorbital gland. Basic Appl Histochem 1979;23:171-7
180. Kelly RB, Oliver C, Hand AR. The effects of vinblastine on acinar cells of the exorbital lacrimal gland of the rat. Cell Tissue Res 1978;195:227-37
181. Krawczuk-Hermanowiczowa O. [Effects of sexual glands on the lacrimal gland. II. Changes in rat lacrimal glands after castration]. Klin Oczna 1983;85:15-7
182. Shaw PH, Held WA, Hastie ND. The gene family for major urinary proteins: expression in several secretory tissues of the mouse. Cell 1983;32:755-61
183. Gubits RM, Lynch KR, Kulkarni AB, et al. Differential regulation of α 2u globulin gene expression in liver, lachrymal gland, and salivary gland. J Biol Chem 1984;259:12803-9
184. Sullivan DA, Bloch KJ, Allansmith MR. Hormonal influence on the secretory immune system of the eye: Androgen regulation of secretory component levels in rat tears. J Immunol 1984;132:1130-5
185. Sullivan DA, Bloch KJ, Allansmith MR. Hormonal influence on the secretory immune system of the eye: androgen control of secretory component production by the rat exorbital gland. Immunology 1984;52:239-46
186. Sullivan DA, Allansmith MR. Hormonal influence on the secretory immune system of the eye: androgen modulation of IgA levels in tears of rats. J Immunol 1985;134:2978-82
187. Cripps MM, Bromberg BB, Welch MH. Gender-dependent lacrimal protein secretion (abstract). Invest Ophthalmol Vis Sci 1986;27 (suppl):25
188. Sullivan DA, Colby E, Hann LE, et al. Production and utilization of a mouse monoclonal antibody to rat IgA: Identification of gender-related differences in the secretory immune system. Immunol Invest 1986;15:311-8
189. Hann LE, Allansmith MR, Sullivan DA. Impact of aging and gender on the Ig-containing cell profile of the lacrimal gland. Acta Ophthalmol 1988;66:87-92
190. Mhatre MC, van Jaarsveld AS, Reiter RJ. Melatonin in the lacrimal gland: first demonstration and experimental manipulation. Biochem Biophys Res Comm 1988;153:1186-92
191. Sullivan DA, Allansmith MR. The effect of aging on the secretory immune system of the eye. Immunology 1988;63:403-10
192. Pangerl A, Pangerl B, Jones DJ, Reiter RJ. β-Adrenoreceptors in the extraorbital lacrimal gland of the syrian hamster. Characterization with [125I]-iodopindolol and evidence of sexual dimorphism. J Neural Transm 1989;77:153-62
193. Sashima M, Hatakeyama S, Satoh M, Suzuki A. Harderianization is another sexual dimorphism of rat exorbital lacrimal gland. Acta Anat 1989;135:303-6
194. Sullivan DA, Hann LE, Yee L, Allansmith MR. Age- and gender-related influence on the lacrimal gland and tears. Acta Ophthalmologica 1990;68:188-94
195. Winderickx J, Hemschoote K, De Clercq N, et al. Tissue-specific expression and androgen regulation of different genes encoding rat prostatic 22-kilodalton glycoproteins homologous to human and rat cystatin. Molec Endocrinol 1990;4:657-67
196. Snyder C, Fullard RJ. Clinical profiles of non dry eye patients and correlations with tear protein levels. Int Ophthalmol 1991;15:383-9
197. De PK. Sex differences in content of peroxidase, a porphyrin containing enzyme, in hamster lacrimal gland, in Abstracts of the International Conference on the Lacrimal Gland, Tear Film and Dry Eye Syndromes: Basic Science and Clinical Relevance (Bermuda); 1992:40
198. Azzarolo AM, Mazaheri AH, Mitchell AK, Warren DW. Sex-dependent parameters related to electrolyte, water and glycoprotein secretion in rabbit lacrimal glands. Curr Eye Res 1993;12:795-802
199. Bromberg BB, Welch MH, Beuerman RW, et al. Histochemical distribution of carbonic anhydrase in rat and rabbit lacrimal gland. Invest Ophthalmol Vis Sci 1993;34:339-48
200. Rocha FJ, Wickham LA, Pena JD, et al. Influence of gender and the endocrine environment on the distribution of androgen receptors in the lacrimal gland. J Steroid Biochem Mol Biol 1993;46:737-49
201. Lorber M, Vidic B. Weights and dimensions of 16 lacrimal glands from human cadavers (abstract). Invest Ophthalmol Vis Sci 1994;35 (suppl):1790
202. van Setten G, Schultz G. Transforming growth factor-α is a constant component of human tear fluid. Graefes Arch Clin Exp Ophthalmol 1994;232:523-6
203. Winderickx J, Vercaeren I, Verhoeven G, Heyns W. Androgen-dependent expression of cystatin-related protein (CRP) in the exorbital lacrimal gland of the rat. J Steroid Biochem Mol Biol 1994;48:165-70
204. Craig JP, Tomlinson A. Effect of age on tear osmolality. Optom Vis Sci. 1995;72:713-7
205. Gao J, Lambert RW, Wickham LA, et al. Androgen control of secretory component mRNA levels in the rat lacrimal gland. J Steroid Biochem Mol Biol 1995;52:239-49
206. Huang Z, Gao J, Wickham LA, Sullivan DA. Influence of gender and androgen treatment on TGF-β1 mRNA levels in the rat lacrimal gland (abstract). Invest Ophthalmol Vis Sci 1995;35(suppl):S991
207. Kenney MC, Brown DJ, Hamdi H. Proteinase activity in normal human tears: male-female dimorphism (abstract). Invest Ophthalmol Vis Sci 1995;36 (suppl):S4606
208. Obata H, Yamamoto S, Horiuchi H, Machinami R. Histopathologic study of the human lacrimal gland. Statistical analysis with special reference to aging. Ophthalmology 1995;102:678-86
209. Ranganathan V, De PK. Androgens and estrogens markedly inhibit expression of a 20-kDa major protein in hamster exorbital lacrimal gland. Biochem Biophys Res Comm 1995;208:412-7
210. Bodelier VM, van Haeringen NJ. Gender related differences in tear fluid protein profiles of mice, in Abstracts of the IVth International Congress of the International Society of Dacryology (Stockholm, Sweden); 1996:24
211. Huang Z, Lambert RW, Wickham A, Sullivan DA. Analysis of cytomegalovirus infection and replication in acinar epithelial cells of the rat lacrimal gland. Invest Ophthalmol Vis Sci 1996;37:1174-86
212. Sullivan DA, Block L, Pena JDO. Influence of androgens and pituitary hormones on the structural profile and secretory activity of the lacrimal gland. Acta Ophthalmol Scand 1996;74:421-35
213. Ueno H, Ariji E, Izumi M, et al. MR imaging of the lacrimal gland. Age-related and gender-dependent changes in size and structure. Acta Radiol 1996 Sep;37:714-9
214. Nava A, Barton K, Monroy DC, Pflugfelder SC. The effects of age, gender, and fluid dynamics on the concentration of tear film epidermal growth factor. Cornea 1997;16:430-8
215. Barton K, Nava A, Monroy DC, Pflugfelder SC. Cytokines and tear function in ocular surface disease. Adv Exp Med Biol 1998;438:461-9
216. Craig JP, Tomlinson A. Age and gender effects on the normal tear film. Adv Exp Med Biol 1998;438:411-5
217. Vercaeren I, Vanaken H, Van Dorpe J, et al. Expression of cystatin-related protein and of the C3-component of prostatic-binding protein during postnatal development in the rat ventral prostate and lacrimal gland. Cell Tissue Res 1998;292:115-28
218. Wickham LA, Rocha AM, Gao J, et al. Identification and hormonal control of sex steroid receptors in the eye. Adv Exp Med Biol 1998;438:95-100
219. Haendler B, Toda I, Sullivan DA, Schleuning WD. Expression of transcripts for cysteine-rich secretory proteins (CRISPs) in the murine lacrimal gland. J Cell Physiol 1999;178:371-8
220. Ranganathan V, Jana NR, De PK. Hormonal effects on hamster lacrimal gland female-specific major 20 kDa secretory protein and its immunological similarity with submandibular gland major male-specific proteins. J Steroid Biochem Mol Biol 1999;70:151-8
221. Remington SG, Lima PH, Nelson JD. Pancreatic lipase-related protein 1 mRNA in female mouse lacrimal gland. Invest Ophthalmol Vis Sci 1999;40:1081-90
222. du Toit R, Situ P, Simpson T, Fonn D. The effects of six months of contact lens wear on the tear film, ocular surfaces, and symptoms of presbyopes. Optom Vis Sci 2001;78:455-62
223. Ricciardi ME, Gesi M, Giannessi E, et al. Comparative analysis of senescent exorbital lacrimal glands in male and female albino rats. J Submicrosc Cytol Pathol 2002;34:167-75
224. Richards SM, Liu M, Sullivan BD, Sullivan DA. Gender-related differences in gene expression of the lacrimal gland. Adv Exp Med Biol 2002;506:121-8
225. Rocha EM, Hirata AE, Carneiro EM, et al. impact of gender on insulin signaling pathway in lacrimal and salivary glands of rats. Endocrine 2002;18:191-9
226. Marcozzi G, Liberati V, Madia F, et al. Age- and gender-related differences in human lacrimal fluid peroxidase activity. Ophthalmologica 2003;217:294-7
227. Verhagen C, Rowshani T, Willekens B, van Haeringen NJ. Spontaneous development of corneal crystalline deposits in MRL/Mp mice. Invest Ophthalmol Vis Sci 1995;36:454-61
228. Henderson JW, Prough WA. Influence of age and sex on flow of tears. Arch Ophthalmol 1950;43:224-31
229. Sorensen T, Jensen FT. Tear flow in normal human eyes. Determination by means of radioisotope and gamma camera. Acta Ophthalmol (Copenh) 1979;57:564-81
230. Sullivan DA, Wickham LA, Rocha EM, et al. Influence of gender, sex steroid hormones and the hypothalamic-pituitary axis on the structure and function of the lacrimal gland. Adv Exp Med Biol 1998;438:11-42
231. Hunger RE, Carnaud C, Vogt I, Mueller C. Male gonadal environment paradoxically promotes dacryoadenitis in nonobese diabetic mice. J Clin Invest 1998;101:1300-9
232. Richards SM, Liu M, Sullivan DA. Effect of gender on gene expression in the mouse lacrimal gland. ARVO e-abstract #1418, 2001 (www.arvo.org)
233. Bruckner R. Uber einem erfolgreich mit perandren behandelten fall von Sjogren'schem symptomen komplex. Ophthalmologica 1945;110:37-42
234. Appelmans M. La Kerato-conjonctivite seche de Gougerot-Sjogren. Arch Ophtalmologie 1948;81:577-88
235. Radnot M, Nemeth B. Testosteronkészítmenyek hatása a könnymirigyre. Orvosi Hetilap 1954;95:580-1
236. Radnot VM, Nemeth B. Wirkung der Testosteronpräparate auf die Tränendrüse. Ophthalmologica 1955;129:376-80
237. Nover A. The influence of testosterone and hypophysine on lacrimal secretion. Arzneimittel-Forschg 1957;7:277-8
238. Cavallero C. The influence of various steroids on the Lowenthal lachrymal glands of the rat. Acta Endocrinol (Copenh) 1960;51(suppl):861
239. Cavallero C, Chiappino G, Milani F, Casella E. Uptake of 35S Labelled sulfate in the exorbital lacrymal glands of adult and newborn rats under different hormonal treatment. Experentia (Basel) 1960;16:429
240. Cavallero C, Morera P. Effect of testosterone on the nuclear volume of exorbital lacrimal glands of the white rat. Experentia 1960;16:285-6
241. Dzierzykray-Rogalska I, Chodynicki S, Wisniewski L. The effect of gonadectomy on the parotid salivary gland and Loeventhal's gland in white mice. Acta Med Polona 1963;2:221-8
242. Carriere R. The influence of the thyroid gland on polyploid cell formation in the external orbital gland of the rat. Am J Anat 1964;115:1-16
243. Quintarelli G, Dellovo MC. Activation of glycoprotein biosynthesis by testosterone propionate on mouse exorbital glands. J Histochem Cytochem 1965;13:361-4
244. Cavallero C, Offner P. Relative effectiveness of various steroids in an androgen assay using the exorbital lacrimal gland of the castrated rat. II. C19-steroids of the 5α-androstane series. Acta Endocrinol (Copenh) 1967;55:131-5
245. Krawczuk-Hermanowiczowa O. Effect of sex hormones on the lacrimal gland. III. Effects of testosterone and oestradiol and of both these hormones jointly on the morphological appearance of the lacrimal gland in castrated rats. Klin Oczna 1983;85:337-9
246. Sullivan DA, Allansmith MR. Hormonal modulation of tear volume in the rat. Exp Eye Res 1986;42:131-9
247. Bizzarro A, Valentini G, Di Marinto G, et al. Influence of testosterone therapy on clinincal and immunological features of autoimmune diseases associated with Klinefelter's syndrome. J Clin Endocrinol Metab 1987;64:32-6
248. Sullivan DA, Allansmith MR. Hormonal influence on the secretory immune system of the eye: endocrine interactions in the control of IgA and secretory component levels in tears of rats. Immunology 1987;60:337-43
249. Sullivan DA, Hann LE, Vaerman JP. Selectivity, specificity and kinetics of the androgen regulation of the ocular secretory immune system. Immunol Invest 1988;17:183-94
250. Ariga H, Edwards J, Sullivan DA. Androgen control of autoimmune expression in lacrimal glands of MRL/Mp-lpr/lpr mice. Clin Immunol Immunopathol 1989;53:499-508
251. Sullivan DA, Hann LE. Hormonal influence on the secretory immune system of the eye: endocrine impact on the lacrimal gland accumulation and secretion of IgA and IgG. J Steroid Biochem 1989;34:253-62
252. Sullivan DA, Kelleher RS, Vaerman JP, Hann LE. Androgen regulation of secretory component synthesis by lacrimal gland acinar cells in vitro. J Immunol 1990;145:4238-44
253. Hann LE, Kelleher RS, Sullivan D.A. Influence of culture conditions on the androgen control of secretory component production by acinar cells from the lacrimal gland. Invest Ophthalmol Vis Sci 1991;32:2610-21
254. Kelleher RS, Hann LE, Edwards JA, Sullivan DA. Endocrine, neural and immune control of secretory component output by lacrimal gland acinar cells. J Immunol 1991;146:3405-12
255. Vendramini AC, Soo CH, Sullivan DA. Testosterone-induced suppression of autoimmune disease in lacrimal tissue of a mouse model (NZB/NZW F1) of Sjogren's Syndrome. Invest Ophthalmol Vis Sci 1991;32:3002-6
256. Sato EH, Ariga H, Sullivan DA. Impact of androgen therapy in Sjogrens syndrome: Hormonal influence on lymphocyte populations and Ia expression in lacrimal glands of MRL/Mp-lpr/lpr mice. Invest Ophthalmol Vis Sci 1992;33:2537-45
257. Vercaeren I, Winderickx J, Devos A, et al. An effect of androgens on the length of the poly(A)-tail and alternative splicing cause size heterogeneity of the messenger ribonucleic acids encoding cystatin-related protein. Endocrinology 1992;131:2496-2502
258. Lambert RW, Kelleher RS, Wickham LA, et al. Neuroendocrinimmune modulation of secretory component production by rat lacrimal, salivary and intestinal epithelial cells. Invest Ophthalmol Vis Sci 1994;35:1192-1201
259. Myal Y, Iwasiow B, Yarmill A, et al. Tissue-specific androgen-inhibited gene expression of a submaxillary gland protein, a rodent homolog of the human prolactin-inducible protein/GCDFP-15 gene. Endocrinology 1994;135:1605-10
260. Rocha FJ, Sato EH, Sullivan BD, Sullivan DA. Effect of androgen analogue treatment and androgen withdrawal on lacrimal gland inflammation in a mouse model (MRL/Mp-lpr/lpr) of Sjogren's syndrome. Reg Immunol 1994;6:270-7261.
261. Sato EH, Sullivan DA. Comparative influence of steroid hormones and immunosuppressive agents on autoimmune expression in lacrimal glands of a female mouse model of Sjogren's syndrome. Invest Ophthalmol Vis Sci 1994;35:2632-42
262. Sullivan DA, Sato EH. Immunology of the lacrimal gland, in Albert DM, Jakobiec, FA (eds). Principles and practice of ophthalmology: Basic sciences. Philadelphia, PA, WB Saunders, 1994:479-86
263. Aumuller G, Arce EA, Heyns W, et al. Immunocytochemical localization of seminal proteins in salivary and lacrimal glands of the rat. Cell Tissue Res 1995;280:171-81
264. Azzarolo AM, Bjerrum K, Maves CA, et al. Hypophysectomy-induced regression of female rat lacrimal glands: Partial restoration and maintenance by dihydrotestosterone and prolactin. Invest Ophthalmol Vis Sci 1995;36:216-26
265. Ono M, Rocha FJ, Sullivan DA. Immunocytochemical location and hormonal control of androgen receptors in lacrimal tissues of the female MRL/Mp-lpr/lpr mouse model of Sjogrens syndrome. Exp Eye Res 1995;61:659-66
266. Vanaken H, Claessens F, Vercaeren I, et al. Androgenic induction of cystatin-related protein and the C3 component of prostatic binding protein in primary cultures from the rat lacrimal gland. Mol Cell Endocrinol 1996;121:197-205
267. Vercaeren I, Vanaken H, Devos A, et al. Androgens transcriptionally regulate the expression of cystatin-related protein and the C3 component of prostatic binding protein in rat ventral prostate and lacrimal gland. Endocrinology 1996;137:4713-20
268. Sullivan DA, Edwards J. Androgen stimulation of lacrimal gland function in mouse models of Sjogren's syndrome. J Steroid Biochem Mol Biol 1997;60:237-45
269. Wickham A, Huang Z, Lambert RW, Sullivan DA. Effect of sialodacryoadenitis virus exposure on acinar epithelial cells from the rat lacrimal gland. Ocular Immunol Immunopathol 1997;5:181-95
270. Claessens F, Vanaken H, Vercaeren I, et al. Androgen-regulated transcription in the epithelium of the rat lacrimal gland. Adv Exp Med Biol 1998;438:43-8
271. Myal Y, Iwasiow B, Cosby H, et al. Analysis of tissue- and hormone-specific regulation of the human prolactin-inducible protein/gross cystic disease fluid protein-15 gene in transgenic mice. J Mol Endocrinol 1998;21:217-23
272. Vanaken H, Vercaeren I, Claessens F, et al. Primary rat lacrimal cells undergo acinar-like morphogenesis on reconstituted basement membrane and express secretory component under androgen stimulation. Exp Cell Res 1998;238:377-88
273. Warren DW, Azzarolo AM, Huang ZM, et al. Androgen support of lacrimal gland function in the female rabbit. Adv Exp Med Biol 1998;438:89-93
274. Azzarolo AM, Wood RL, Mircheff AK, et al. Androgen influence on lacrimal gland apoptosis, necrosis, and lymphocytic infiltration. Invest Ophthalmol Vis Sci 1999;40:592-602
275. Kao WW, Wang IJ, Spaulding et al. Overexpression of biglycan induces ocular surface disorders in Ktcnpr-Bgln transgenic mice. Cornea 2000;19(Suppl 2):S98
276. Vanaken H, Gerard RD, Verrijdt G, et al. Tissue-specific androgen responses in primary cultures of lacrimal epithelial cells studied by adenoviral gene transfer. J Steroid Biochem Mol Biol 2001;78:319-28
277. Liu M, Richards SM, Schirra F, et al. Identification of androgen-regulated genes in the lacrimal gland. Adv Exp Med Biol. 2002;506(Pt A):129-35
278. Ebling FJ, Ebling E, Randall V, Skinner J. The effects of hypophysectomy and of bovine growth hormone on the responses to testosterone of prostate, preputial, harderian and lachrymal glands and of brown adipose tissue in the rat. J Endocr 1975;66:401-6
279. Sullivan DA, Suzuki T, Schirra F, Richards SM. Sex and sex steroid influence on gene expression in mouse lacrimal and meibomian glands (abstract). Intl Congress Eye Research, Sydney, Australia, August 2004
280. Schonthal AH, Warren DW, Stevenson D, et al. Proliferation of lacrimal gland acinar cells in primary culture. Stimulation by extracellular matrix, EGF, and DHT. Exp Eye Res 2000;70:639-49
281. Kyprianou N, Isaacs JT. Activation of programmed cell death in the rat ventral prostate after castration. Endocrinology 1988;122:552-62
282. Lagresa MNS, Suarez NM, Lescaille DV, Lagresa CMS. Inductores de lagrimas: Androgenos y gammaglobulinas humanas. Rev Cubana Oftalmol 2000;13:35-43
283. Worda C, Nepp J, Huber JC, Sator MO. Treatment of keratoconjunctivitis sicca with topical androgen. Maturitas 2001;37:209-12
284. Connor CG, Primo EJ. A weak androgenic artificial tear solution decreases the osmolarity of dry eye patients (abstract). Invest Ophthalmol Vis Sci 2001;41 (suppl):S30
285. Sullivan DA, Krenzer KL, Sullivan BD, et al. Does androgen insufficiency cause lacrimal gland inflammation and aqueous tear deficiency? Invest Ophthalmol Vis Sci 1999;40:1261-5
286. He WW, Kumar MV, Tindall DJ. A frame-shift mutation in the androgen receptor gene causes complete androgen insensitivity in the testicular-feminized mouse. Nucleic Acids Res 1991;19:2373-8
287. Murphy L, O'Shaughnessy PJ: Testicular steroidogenesis in the testicular feminized (Tfm) mouse: loss of 17 α-hydroxylase activity. J Endocrinol 1991;131:443-9
288. Tsai M-J, Clark JH, Schrader WT, O'Malley BW. Mechanisms of action of hormones that act as transcription-regulatory factors, in Wilson JD, Foster DW, Kronenberg HM, Larsen PR (eds). Williams textbook of endocrinology. Philadelphia: WB Saunders, 1998
289. McPhaul MJ, Young M. Complexities of androgen action. J Am Acad Dermatol 2001;45:S87-94
290. Simental JA, Sar M, Lane MV, et al. Transcriptional activation and nuclear targeting signals of the human androgen receptor. J Biol Chem 1992;266:510-8
291. Rundlett SE, Wu X-P, Miesfeld RL. Functional characterizations of the androgen receptor confirm that the molecular basis of androgen action is transcriptional regulation. Mol Endocrinol 1990;4:708-14
292. Mendelsohn LG. Prostate cancer and the androgen receptor: strategies for the development of novel therapeutics. Prog Drug Res 2000;55:213-33
293. Sullivan DA, Edwards JA, Wickham LA, et al. Identification and endocrine control of sex steroid binding sites in the lacrimal gland. Curr Eye Res 1996;15:279-91
294. Ota M, Kyakumoto S, Nemoto T. Demonstration and characterization of cytosol androgen receptor in rat exorbital lacrimal gland. Biochem Internat 1985;10:129-35
295. Tan J, Joseph DR, Quarmby VE, et al. The rat androgen receptor: primary structure, autoregulation of its messenger ribonucleic acid, and immunocytochemical localization of the receptor protein. Mol Endocrinol 1988;2:1276-85
296. Quarmby VE, Yarbrough WG, Lubahn DB, et al. Autologous down-regulation of androgen receptor messenger ribonucleic acid. Mol Endocrinol 1990;4:22-8
297. Krongrad A, Wilson CM, Wilson JD, et al. Androgen increases androgen receptor protein while decreasing receptor mRNA in LNCaP cells. Mol Cell Endocrinol 1991;76:79-88
298. Mora GR, Mahesh VB. Autoregulation of the androgen receptor at the translational level: testosterone induces accumulation of androgen receptor mRNA in the rat ventral prostate polyribosomes. Steroids 1999;64:587-91
299. Takane KK, George FW, Wilson JD. Androgen receptor of rat penis is down-regulated by androgen. Am J Physiol 1990;258:E46-50
300. Devos A, Claessens F, Heyns W, et al. Distinctive interactions of nuclear proteins on the highly homologous promoter regions of two differentially androgen-regulated cystatin-related protein genes (abstract), in Abstracts of the 12th International Symposium of the Journal of Steroid Biochemistry & Molecular Biology (Berlin, Germany); 1995;68 p
301. Lee DK, Chang C. Endocrine mechanisms of disease: Expression and degradation of androgen receptor: mechanism and clinical implication. J Clin Endocrinol Metab 2003;88:4043-54
302. Loy CJ, Yong EL. Sex, infertility and the molecular biology of the androgen receptor. Curr Opin Obstet Gynecol 2001;13:315-21
303. Brinkmann AO. Molecular basis of androgen insensitivity. Mol Cell Endocrinol 2001;179:105-9
304. Brann DW, Hendry LB, Mahesh VB. Emerging diversities in the mechanism of action of steroid hormones. J Steroid Biochem Mol Biol 1995;52:113-33
305. Wunderlich F, Benten WP, Lieberherr M, et al. Testosterone signaling in T cells and macrophages. Steroids 2002;67:535-8
306. Zinder O, Dar DE. Neuroactive steroids: their mechanism of action and their function in the stress response. Acta Physiol Scand 1999;167:181-8
307. Lu SF, Mo Q, Hu S, et al. Dehydroepiandrosterone upregulates neural androgen receptor level and transcriptional activity. J Neurobiol 2003;57:163-71
308. Sullivan SD, Moenter SM. Neurosteroids alter gamma-aminobutyric acid postsynaptic currents in gonadotropin-releasing hormone neurons: a possible mechanism for direct steroidal control. Endocrinology 2003;144:4366-75
309. Lewin DI: From outside or in, sex hormones tweak prostate cells. J NIH Res 1996;8:29-30
310. Culig Z, Hobisch A, Cronauer MV, et al. Activation of the androgen receptor by polypeptide growth factors and cellular regulators. World J Urol 1995;13:285-9
311. Culig Z. Role of the androgen receptor axis in prostate cancer. Urology 2003;62(5 Suppl 1):21-6
312. Lima PH, Georges SA, Remington SG, Nelson JD. mRNA in mouse lacrimal gland with homology to salivary androgen-binding protein (abstract). Invest Ophthalmol Vis Sci 1997;38 (suppl):S148
313. Labrie F, Bélanger A, Simard J, et al. DHEA and peripheral androgen and estrogen formation: intracrinology. Ann NY Acad Sci 1995;774:16-28
314. Labrie F, Bélanger A, Cusan L, Gomez JL, Candas B. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. J Clin Endocrinol Metab 1997;82:2396-2402
315. Bélanger A, Candas B, Dupont A, et al. Changes in serum concentrations of conjugated and unconjugated steroids in 40- to 80-year-old men. J Clin Endocrinol Metab 1994;79:1086-90
316. Labrie F. Intracrinology. Mol Cell Endocrinol 1991;78:C113-C118
317. Bélanger A. Determination of non-conjugated and conjugated steroids in human plasma, in Gorog S (ed): Proc 5th Symp Analysis Steroids, 1993;99-110
318. Labrie F, Bélanger A, Cusan L, Candas B. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology. J Clin Endocrinol Metab 1997;82:2403-9
319. Labrie F, Diamond P, Cusan L, et al. Effect of 12-month DHEA replacement therapy on bone, vagina, and endometrium in postmenopausal women. J Clin Endocrinol Metab 1997;82:3498-3505
320. Labrie F, Bélanger A, Luu-The V, et al. DHEA and the intracrine formation of androgens and estrogens in peripheral target tissues: Its role during aging. Steroids 1998;63:322-8
321. Labrie F, Luu-The V, Lin SX, et al. The key role of 17β-hydroxysteroid dehydrogenases in sex steroid biology. Steroids 1997;62:148-58
322. Schirra F, Suzuki T, Dickinson DP, et al. Identification of steroidogenic enzyme mRNAs in human ocular surface tissues and cells (abstract). ARVO e-abstract #1025, 2003 (www.arvo.org)
323. Sullivan DA. Influence of the hypothalamic-pituitary axis on the androgen regulation of the ocular secretory immune system. J Steroid Biochem. 1988;30:429-33
324. O'Sullivan NL, Montgomery PC, Sullivan DA. Ocular mucosal immunity, in Ogra PL, Mestecky J, Lamm ME, et al (eds). Handbook of mucosal immunology, 3rd Edition. Orlando, FL, Academic Press; 2004, in press
325. Meek B, Speijer D, de Jong PT, et al. The ocular humoral immune response in health and disease. Prog Retin Eye Res 2003;22:391-415
326. Saitoh-Inagawa W, Hiroi T, Yanagita M, et al. Unique characteristics of lacrimal glands as a part of mucosal immune network: high frequency of IgA-committed B-1 cells and NK1.1+ αβ T cells. Invest Ophthalmol Vis Sci 2000;41:138-44
327. Sack RA, Nunes I, Beaton A, Morris C. Host-defense mechanism of the ocular surfaces. Biosci Rep 2001;21:463-80
328. Sullivan DA, Allansmith MR. Source of IgA in tears of rats. Immunology 1994;53:791-9
329. Peppard JV, Montgomery PC. Studies on the origin and composition of IgA in rat tears. Immunology 1987;62:194-8
330. Sullivan DA. Ocular mucosal immunity, in Ogra PL, Mestecky J, Lamm ME, (eds). Handbook of mucosal immunology, 2nd Edition. Orlando, FL, Academic Press; 1999, pp 1241-81
331. Verrijdt G, Schoenmakers E, Alen P, et al. Androgen specificity of a response unit upstream of the human secretory component gene is mediated by differential receptor binding to an essential androgen response element. Mol Endocrinol 1999;13:1558-70
332. Sullivan DA, Bélanger A, Cermak JM, et al. Are women with Sjogren's syndrome androgen deficient? J Rheumatology 2003;20:2413-9
333. Nestler JE. Interleukin-1 stimulates the aromatase activity of human placental cytotrophoblasts. Endocrinology 1993;132:566-70
334. Purohit A, Ghilchik MW, Duncan L, et al. Aromatase activity and interleukin-6 production by normal and malignant breast tissues. J Clin Endocrinol Metab 1995;80:3052-8
335. Macdiarmid F, Wang D, Duncan LJ, et al. Stimulation of aromatase activity in breast fibroblasts by tumor necrosis factor α. Mol Cell Endocrinol 1994;106:17-21
336. Speirs V, Adams EF, White MC. The anti-estrogen tamoxifen blocks the stimulatory effects of interleukin-6 on 17 β-hydroxysteroid dehydrogenase activity in MCF-7 cells. J Steroid Biochem Mol Biol 1993;46:605-11
337. Kolkowski E, Coll J, Roure-Mir C, et al. Cytokine mRNA expression in minor salivary gland biopsies of primary Sjogren's syndrome (abstract). J Rheumatol 1997;50(suppl):45
338. Elwaleed M, Zhu J, Deng G-M, et al. Augmented levels of macrophage and Th1 cell-derived cytokine mRNA in MRL/lpr mice submandibular glands (abstract). J Rheumatol 1997; 50(suppl):45
339. Cauli A, Yanni G, Pitzalis C, et al. Cytokine and adhesion molecule expression in the minor salivary glands of patients with Sjogrens syndrome and chronic sialadenitis. Ann Rheum Dis 1995;54:209-15
340. Fox PC, Grisius MM, Sun D, Emmert-Buck M. Cytokines in saliva and salivary glands in primary Sjogren's syndrome (abstract). J Rheumatol 1997;50(suppl):38
341. Takahashi M, Ishimaru N, Yanagi K, et al. High incidence of autoimmune dacryoadenitis in male non-obese diabetic (NOD) mice depending on sex steroid. Clin Exp Immunol 1997;109:555-61
342. Hunger RE, Muller S, Laissue JA, et al. Inhibition of submandibular and lacrimal gland infiltration in nonobese diabetic mice by transgenic expression of soluble TNF-receptor p55. J Clin Invest 1996;98:954-61
343. Sokoloff MH, Tso CL, Kaboo R, et al. In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines. Cancer 1996;77:1862-72
344. Blais Y, Sugimoto K, Carriere MC, et al. Interleukin-6 inhibits the potent stimulatory action of androgens, glucocorticoids and interleukin-1 α on apolipoprotein D and GCDFP-15 expression in human breast cancer cells. Int J Cancer 1995;62:732-7
345. Steinberg AD, Roths JB, Murphy ED, et al. Effects of thymectomy or androgen administration upon the autoimmune disease of MRL/Mp-lpr/lpr mice. J Immunol 1980;125:871-3
346. Shear HL, Wofsy D, Talal N. Effects of castration and sex hormones on immune clearance and autoimmune disease in MRL/Mp-lpr/lpr and MRL/Mp-+/+ mice. Clin Immunol Immunopathol 1983;26:361-9
347. Brick JE, Walker SE, Wise KS. Hormone control of autoantibodies to calf thymus nuclear extract (CTE) and DNA in MRL-lpr and MRL-+/+ mice. Clin Immunol Immunopathol 1988;46:68-81
348. Gao J, Stern M. Modulators of apoptosis in the lacrimal gland of dry eye dogs (abstract). J Rheumatol 1997; 50(suppl):43
349. Valtysdottir ST, Wide L, Hallgren. Low serum dehydroepiandrosterone sulfate in women with primary Sjogren's syndrome as an isolated sign of impaired HPA axis function. J Rheumatol 2001;28:1259-65
350. Jungers P, Khalil N, Pelissier C, et al. Low plasma androgens in women with active or quiescent systemic lupus erythematosus. Arthritis Rheum 1982;25:454-7
351. Lahita RG, Bradlow HL, Ginzler E, et al. Low plasma androgens in women with systemic lupus erythematosus. Arthritis Rheum 1987;30:241-8
352. Derksen RH. Dehydroepiandrosterone (DHEA) and systemic lupus erythematosus. Semin Arthritis Rheum 1998;27:335-47
353. Masi AT, Josipovic DB, Jefferson WE. Low adrenal androgenic-anabolic steroids in women with rheumatoid arthritis (RA): Gas-liquid chromatographic studies of RA patients and matched normal control women indicating decreased 11-deoxy-17-ketosteroid excretion. Semin Arthritis Rheum 1984;14:1-23
354. Cutolo M, Masi AT. Do androgens influence the pathophysiology of rheumatoid arthritis? Facts and hypotheses. J Rheumatol 1998;25:1041-7
355. Cutolo M, Foppiani L, Prete C, et al. Hypothalamic-pituitary-adrenocortical axis function in premenopausal women with rheumatoid arthritis not treated with glucocorticoids. J Rheumatol 1999;26:282-8
356. Masi AT, Bijlsma JW, Chikanza IC, et al. Neuroendocrine, immunologic, and microvascular systems interactions in rheumatoid arthritis: physiopathogenetic and therapeutic perspectives. Semin Arthritis Rheum 1999;29:65-81
357. Fehér KG, Fehér T. Plasma dehydroepiandrosterone, dehydroepiandrosterone sulphate and androsterone sulphate levels and their interaction with plasma proteins in rheumatoid arthritis. Exp Clin Endocrinol 1984;84:197-202
358. Sambrook PN, Eisman JA, Champion GD, Pocock NA. Sex hormone status in postmenopausal women with rheumatoid arthritis. Arthritis Rheum 1988;31:973-8
359. Beeson PB. Age and sex associations of 40 autoimmune diseases. Am J Med 1994;96:457-6
360. Ahmed SA, Penhale WJ, Talal N. Sex hormones, immune responses and autoimmune diseases. Am J Pathol 1985;121:531-51
361. Homo-Delarche F, Fitzpatrick F, Christeff N, et al. Sex steroids, glucocorticoids, stress and autoimmunity. J Steroid Biochem Mol Biol 1991;40:619-37
362. Olsen NJ, Kovacs WJ. Gonadal steroids and immunity. Endocrinol Rev 1996;17:369-84
363. Cutolo M, Sulli A, Seriolo B, Masi AT. Estrogens, the immune response and atoimmunity. Clin Exp Rheumatol 1995;13:217-26
364. Kanda N, Tsuchida T, Tamaki K. Estrogen enhancement of anti-double-stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Arthritis Rheum 1999;42:328-37
365. Kanda N, Tsuchida T, Tamaki K. Testosterone suppresses anti-DNA antibody production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Arthritis Rheum 1997;40:1703-11
366. Jansson L, Holmdahl R. Estrogen-mediated immunosuppression in autoimmune diseases. Inflamm Res 1998;47:290-301
367. Araneo BA, Dowell T, Diegel M, Daynes RA. Dihydrotestosterone exerts a depressive influence on the production of interleukin-4 (IL-4), IL-5, and γ-interferon, but not IL-2 by activated murine T cells. Blood 1991;78:688-99
368. Li ZG, Danis VA, Brooks PM. Effect of gonadal steroids on the production of IL-1 and IL-6 by blood mononuclear cells in vitro. Clin Exp Rheumatol 1993;11:157-62
369. Harbuz MS, Perveen-Gill Z, Lightman SL, Jessop DS. A protective role for testosterone in adjuvant-induced arthritis. Br J Rheumatol 1995;34:1117-22
370. Cutolo M, Balleari E, Giusti M, et al. Androgen replacement therapy in male patients with rheumatoid arthritis. Arthritis Rheum 1991;34:1-5
371. Shoenfeld Y, Krause I, Blank M. New methods of treatment in an experimental murine model of systemic lupus erythematosus induced by idiotypic manipulation. Ann Rheum Dis 1997;56:5-11
372. Moutsopoulos HM. Sjogren's syndrome: Autoimmune epithelitis. Clin Immunol Immunopathol 1994;72:162-5
373. Mamalis N, Harrison DY, Hiura G, et al. Dry eyes and testosterone deficiency in women (abstract), in Abstracts of the Centennial Annual Meeting of the American Academy of Ophthalmology 1996; p 132
374. Gurwood AS, Gurwood I, Gubman DT, Brzezicki LJ. Idiosyncratic ocular symptoms associated with the estradiol transdermal estrogen replacement patch system. Optom Vis Sci. 1995;72:29-33
375. Yagyu H, Kitamine T, Osuga J, et al. Absence of ACAT-1 attenuates atherosclerosis but causes dry eye and cutaneous xanthomatosis in mice with congenital hyperlipidemia. J Biol Chem 2000;275:21324-30
376. Huang SM, Azzarolo AM, Mircheff AK, et al. Does estrogen directly affect lacrimal gland function? (abstract). Invest Ophthalmol Vis Sci 1995;36(suppl):S651
377. Brennan NA, Efron N. Symptomatology of HEMA contact lens wear. Optom Vis Sci 1989;66:834-8
378. Medical economics data of Medical Economics Co, Inc. Physicians Desk Reference. Montvale, NJ, 1993:895-8
379. Akramian J, Wedrich A, Nepp J, Sator M. Estrogen therapy in keratoconjunctivitis sicca. Adv Exp Med Biol 1998;438:1005-9
380. Prijot E, Barzin L, Destexhe B. Trial of hormone treatment of dry kerato-conjunctivitis. Bull Soc Belge Ophtalmol 1972;162:795-800
381. Laine M, Tenovuo J. Effect on peroxidase activity and specific binding of the hormone 17β-estradiol and rat salivary glands. Arch Oral Biol 1983;8:847-52
382. Valde G, Ghini M, Gammi L, et al. [Effects of triphasic oral contraceptives on lacrimal secretion]. Ophtalmologie 1988;2:129-30
383. Lubkin V, Kramer P, Nash R, Bennett G. Evaluation of safety and efficacy of topical 17β-estradiol, 0.1% and 0.25%, in postmenopausal dry eye syndrome (abstract), in Abstracts of the Second International Conference on the Lacrimal Gland, Tear Film and Dry Eye Syndromes: Basic Science and Clinical Relevance (Bermuda), 1996, p 160
384. Ostachowicz M, Jettmar A, Laukienicki A. [Treatment of Sjogren's syndrome with female sex hormones.] Wiad Lek 1973;11:1075-7
385. Lubkin V, Nash R, Kramer P. The treatment of perimenopausal dry eye syndrome with topical estradiol (abstract). Invest Ophthalmol Vis Sci 1992;33(suppl):1289
386. Schild G, Schauersberger J. About the effect of an estrogen-ointment on the ocular conjunctiva in postmenopausal women with keratoconjunctivitis sicca (abstract). Cornea 2000;9(suppl 2):S121
387. Azzarolo AM, Kaswan RL, Mircheff AK, Warren DW. Androgen prevention of lacrimal gland regression after ovariectomy of rabbits (abstract). Invest Ophthalmol Vis Sci 1994;35(suppl):1793
388. Coles N, Lubkin V, Kramer P, et al. Hormonal analysis of tears, saliva, and serum from normals and postmenopausal dry eyes (abstract). Invest Ophthalmol Vis Sci 1988;29(suppl):48
389. Krasso I. Die behandlung der erkrankungen des vorderen bulbusabschnittes mit buckys grenzstrahlen. Ztschr f Augenh 1930;71:1-11
390. Azzarolo AM, Mircheff AK, Kaswan R, Warren DW. Hypothesis for an indirect role of estrogens in maintaining lacrimal gland function (abstract). Invest Ophthalmol Vis Sci 1993;34(suppl):1466
391. Suzuki T, Schaumberg DA, Sullivan BD, et al. Do estrogen and progesterone play a role in the dry eye of Sjogren's syndrome? Ann NY Acad Sci 2002;966:223-5
392. Marcozzi G, Liberati V, Madia F, et al. Effect of hormone replacement therapy on lacrimal fluid peroxidase activity in woman. Maturitas 2003;45:225-9
393. Azzarolo AM, Eihausen H, Schechter J. Estrogen prevention of lacrimal gland cell death and lymphocytic infiltration. Exp Eye Res 2003;77:347-54
394. Skynner MJ, Sim JA, Herbison AE. Detection of estrogen receptor α and β messenger ribonucleic acids in adult gonadotropin-releasing hormone neurons. Endocrinology 1999;140:5195-5201
395. Brannan CI, Dees EC, Ingram RS, Tilghman SM. The product of the H19 gene may function as an RNA. Mol Cell Biol 1990;10:28-36
396. Kuiper GGJ, Carlsson B, Grandien K, et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptor α and β. Endocrinology 1997;138:863-70
397. Smithson G, Couse JF, Lubahn DB, et al. The role of estrogen receptors and androgen receptors in sex steroid regulation of B lymphopoiesis. J Immunol 1998;16:27-34
398. Lubahn DB, Moyer JS, Golding TS, et al. Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc Natl Acad Sci USA 1993;90:11162-6
399. Kuiper GGJ, Enmark E, Pelto-Huikko M, et al. Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 1996;93:5925-30
400. Korach KS. Insights from the study of animals lacking functional estrogen receptor. Science 1994;266:1524-7
401. Couse JF, Curtis SW, Washburn TF, et al. Analysis of transcription and estrogen insensitivity in the female mouse after targeted disruption of the estrogen receptor gene. Mol Endocrinol 1995;9:1441-54
402. Shughrue P, Scrimo P, Lane M, et al. The distribution of estrogen receptor-β mRNA in forebrain regions of the estrogen receptor-α knockout mouse. Endocrinology 1997;138:5649-52
403. Hall JM, McDonnell DP. The estrogen receptor β-isoform (ER β) of the human estrogen receptor modulates ERα transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology 1999;140:5566-78
404. Mitchner NA, Garlick C, Ben-Jonathan N. Cellular distribution and gene regulation of estrogen receptors α [SE1] and β in the rat pituitary gland. Endocrinology 1998;139:3976-83
405. McDonnell DP, Norris JD. Connections and regulation of the human estrogen receptor. Science 2002;296:1642-4
406. Ravizza T, Galanopoulou AS, Veliskova J, Moshe SL. Sex differences in androgen and estrogen receptor expression in rat substantia nigra during development: an immunohistochemical study. Neuroscience 2002;115:685-96
407. Sakaguchi H, Fujimoto J, Aoki I, Tamaya T. Expression of estrogen receptor α and β in myometrium of premenopausal and postmenopausal women. Steroids 2003;68:11-9
408. Shaw JA, Udokang K, Mosquera JM, et al. Oestrogen receptors α and β differ in normal human breast and breast carcinomas. J Pathol 2002;198:450-7
409. Zhou Q, Nie R, Prins GS, et al. Localization of androgen and estrogen receptors in adult male mouse reproductive tract. J Androl 2002;23:870-81
410. Okuda Y, Hirata S, Watanabe N, et al. Novel splicing events of untranslated first exons in human estrogen receptor a (ERα) gene. Endocr J 2003;50:97-104
411. Chi A, Chen X, Chirala M, Younes M. Differential expression of estrogen receptor β isoforms in human breast cancer tissue. Anticancer Res 2003;23:211-6
412. Sasaki M, Kaneuchi M, Fujimoto S, et al. Hypermethylation can selectively silence multiple promoters of steroid receptors in cancers. Mol Cell Endocrinol 2003;202:201-7
413. Lindberg MK, Moverare S, Skrtic S, et al. Estrogen receptor (ER)-β reduces ERα-regulated gene transcription, supporting a "Ying Yang" relationship between ERα and ERβ in mice. Mol Endocrinol 2003;17:203-8
414. Prange-Kiel J, Wehrenberg U, Jarry H, Rune GM. Para/autocrine regulation of estrogen receptors in hippocampal neurons. Hippocampus 2003;13:226-34
415. Poola I. Molecular assay to generate expression profile of eight estrogen receptor α isoform mRNA copy numbers in picogram amounts of total RNA from breast cancer tissues. Anal Biochem 2003; 314:217-26
416. Swope D, Harrell JC, Mahato D, Korach KS. Genomic structure and identification of a truncated variant message of the mouse estrogen receptor α gene. Gene 2002;294:239-47
417. Herrington DM. Role of estrogen receptor-α in pharmacogenetics of estrogen action. Curr Opin Lipidol 2003;14:145-50
418. Ongphiphadhanakul B. Genetic polymorphisms of estrogen receptor-α: Possible implications for targeted osteoporosis therapy. Am J Pharmacogenomics 2003;3:5-9
419. Albagha OM, Ralston SH. Genetic determinants of susceptibility to osteoporosis. Endocrinol Metab Clin North Am 2003;32:65-81
420. Weihua Z, Ekman J, Almkvist A, et al. Involvement of androgen receptor in 17β-estradiol-induced cell proliferation in rat uterus. Biol Reprod 2002;67:616-23
421. Cyr M, Calon F, Morissette M, et al. Drugs with estrogen-like potency and brain activity: potential therapeutic application for the CNS. Curr Pharm Des 2000;6:1287-1312
422. Simoncini T, Rabkin E, Liao JK. Molecular basis of cell membrane estrogen receptor interaction with phosphatidylinositol 3-kinase in endothelial cells. Arterioscler Thromb Vasc Biol 2003;23:198-203
423. Wade CB, Dorsa DM. Estrogen activation of cyclic adenosine 5′-monophosphate response element-mediated transcription requires the extracellularly regulated kinase/mitogen-activated protein kinase pathway. Endocrinology 2003;144:832-8
424. Qiu J, Bosch MA, Tobias SC, et al. Rapid signaling of estrogen in hypothalamic neurons involves a novel G-protein-coupled estrogen receptor that activates protein kinase C. J Neurosci 2003;23:9529-40
425. Homo-Delarche F, Durant S. Hormones, neurotransmitters and neuropeptides as modulators of lymphocyte functions, in Rola-Pleszczynski M (ed). Handbook of immunopharmacology. London, Academic Press, 1994, pp 169-240
426. Ahmed SA, Talal N. Sex hormones and the immune system, part 2. Animal data. Bailliere's Clin Rheumatol 1990;4:13-31
427. Ahmed SA, Talal N. Importance of sex hormones in systemic lupus erythematosus, in Wallace D, Hahn B (eds). Dubois' lupus erythematosus. Philadelphia: Lea & Febiger, 1993, pp 148-56
428. Van Griensven M, Bergijk EC, Baelde JJ, et al. Differential effects of sex hormones on autoantibody production and proteinuria in chronic graft-versus-host disease-induced experimental lupus nephritis. Clin Exp Immunol 1997;107:254-60
429. Wilder RL. Neuroendocrine-immune system interactions and autoimmunity. Annu Rev Immunol 1995;13:307-38
430. Sthoeger ZM, Zinger H, Mozes E. Beneficial effects of the anti-oestrogen tamoxifen on systemic lupus erythematosus of (NZBxNZW)F1 female mice are associated with specific reduction of IgG3 autoantibodies. Ann Rheum Dis 2003;62:341-6
431. Liu HB, Loo KK, Palaszynski K, et al. Estrogen receptor α mediates estrogen's immune protection in autoimmune disease. J Immunol 2003;171:6936-40
432. Whitacre CC. Sex differences in autoimmune disease. Nat Immunol 2001;2:777-80
433. Ahmed SA, Aufdemorte TB, Chen JR, et al. Estrogen induces the development of autoantibodies and promotes salivary gland lymphoid infiltrates in normal mice. J Autoimmun 1989;2:543-52
434. Carlsten H, Tarkowski A, Holmdahl R, Nilsson LA. Oestrogen is a potent disease accelerator in SLE-prone MRL lpr/lpr mice. Clin Exp Immunol 1990;80:467-73
435. Talal N. Natural history of murine lupus. Modulation by sex hormones. Arthritis Rheum 1978;21(5 suppl):S58-63
436. Roubinian JR, Talal N, Greenspan JS, et al. Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies, and glomerulonephritis in NZB/NZW F1 mice. J Exp Med 1978;147:1568-83
437. Nelson JL, Steinberg AD. Sex steroids, autoimmunity and autoimmune diseases, in Berczi I, Kovacs K (eds). Hormones and immunity. Lancaster, UK, MTP Press, 1987, pp 93-119
438. Apelgren LD, Bailey DL, Fouts RL, et al. The effect of a selective estrogen receptor modulator on the progression of spontaneous autoimmune disease in MRL lpr/lpr mice. Cell Immunol 1996;173:55-63
439. Onodera K, Sasano H, Ichinohasama R, Ooya K. Immunolocalization of aromatase in human minor salivary glands of the lower lip with primary Sjogren's syndrome. Pathol Int 1998;48:786-90
440. Ishimaru N, Saegusa K, Yanagi K, et al. Estrogen deficiency accelerates autoimmune exocrinopathy in murine Sjogren's syndrome through fas-mediated apoptosis. Am J Pathol 1999;155:173-81
441. Haneji N, Nakamura T, Takio K, et al. Identification of α-fodrin as a candidate autoantigen in primary Sjogren's syndrome. Science 1997;276:604-7
442. Grossman CJ. Are there underlying immune-neuroendocrine interactions responsible for immunological sexual dimorphism? Prog NeuroEndocrinImmunol 1990;3:75-82
443. Grossman CJ. Regulation of the immune system by sex steroids. Endocr Rev 1984;5:435-55
444. Hattori M, Brandon MR. Thymus and the endocrine system: ovarian dysgenesis in neonatally thymectomized rats. J Endocrinol 1979;83:101-11
445. Verheul HA, Verveld M, Hoefakker S, Schuurs AH. Effects of ethinylestradiol on the course of spontaneous autoimmune disease in NZB/W and NOD mice. Immunopharmacol Immunotoxicol 1995;17:163-80
446. Keisler LW, Kier AB, Walker SE. Effects of prolonged administration of the 19-nor-testosterone derivatives norethindrone and norgestrel to female NZB/W mice: comparison with medroxyprogesterone and ethinyl estradiol. Autoimmunity 1991;9:21-32
447. Dhaher YY, Chan K, Greenstein BD, et al. Impaired estrogen priming of progesterone receptors in uterus of MRL/MP-lpr/lpr mice, a model of systemic lupus erythematosus (SLE). Int J Immunopharmacol 2000;22:537-45
448. Dhaher YY, Greenstein B, de Fougerolles Nunn E, et al. Strain differences in binding properties of estrogen receptors in immature and adult BALB/c and MRL/MP-lpr/lpr mice, a model of systemic lupus erythematosus. Int J Immunopharmacol 2000;22:247-54
449. Rider V, Jones SR, Evans M, Abdou NI. Molecular mechanisms involved in the estrogen-dependent regulation of calcineurin in systemic lupus erythematosus T cells. Clin Immunol 2000;95:124-34
450. Evans V, Millar TJ, Eden JA, Willcox MDP. Menopause, hormone replacement therapy and tear function. Adv Exp Med Biol 2002;506:1029-33
451. Okon A, Jurowski P. Gos R. The influence of the hormonal replacement therapy on the amount and stability of the tear film among peri- and postmenopausal women. Klin Oczna 2001;103:177-81
452. Wenderlein M, Mattes S. The "dry eye" phenomenon and ovarian function. Study of 700 women pre- and postmenopausal. Zentralbl Gynakol 1996;118:643-9
453. Pelit A, Bagis T, Kayaselcuk F, et al. Tear function tests and conjunctival impression cytology before and after hormone replacement therapy in postmenopausal women. Eur J Ophthalmol 2003;13:337-42
454. Tomlinson A, Pearce EI, Simmons PA, Blades K. Effect of oral contraceptives on tear physiology. Ophthalmic Physiol Opt 2001;21:9-16
455. Hann LE, Tatro J, Sullivan DA. Morphology and function of lacrimal gland acinar cells in primary culture. Invest Ophthalmol Vis Sci 1989;30:145-58
456. Tabbara KF, Frayha RA. Alternate-day steroid therapy for patients with primary Sjogren's syndrome. Ann Ophthalmol 1983;15:358-61
457. Jones BR, Coop HV. The management of keratoconjunctivitis sicca. Trans Ophthalmol Soc UK 1996;85:379-89
458. Nasu M, Matsubara O, Yamamoto H. Post-mortem prevalence of lymphocytic infiltration of the lacrymal gland: a comparative study in autoimmune and non-autoimmune diseases. J Pathol 1984;143:11-5
459. Fox PC, Datiles M, Atkinson JC, et al. Prednisone and piroxicam for treatment of primary Sjogren's syndrome. Clin Exp Rheumatol 1993;11:149-56
460. Singh G, Kaur J. Iatrogenic dry eye: late effect of topical steroid formulations. J Indian Med Assoc 1992;90:235-7
461. Wilson SE, Lloyd SA, Kennedy RH. Fibroblast growth factor receptor-1, interleukin-1 receptor, and glucocorticoid receptor messenger RNA production in the human lacrimal gland. Invest Ophthalmol Vis Sci 1993;34:1977-82
462. Maskin SL, Anderson B, Chodosh J, et al. Loteprednol etabonate 0.5% (Lotemax) versus vehicle in the management of patients with KCS and at least moderate inflammation (abstract). ARVO e-abstract #686, 2003 (www.arvo.org)
463. Marsh P, Pflugfelder SC. Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjogren syndrome. Ophthalmology 1999;106:811-6
464. Avunduk AM, Avunduk MC, Varnell ED, Kaufman HE. The comparison of efficacies of topical corticosteroids; and nonsteroidal anti-inflammatory drops on dry eye patients: a clinical and immunocytochemical study. Am J Ophthalmol 2003;136:593-602
465. Bott E, Blair-West JR, Coghlan JP, et al. Action of aldosterone on the lachrymal gland. Nature 1966;210:102
466. Perkovich CL, Ubels JL, Lee SY, Soprano DR. Cellular retinol-binding protein and cellular retinoic acid-binding protein in the lacrimal gland. Exp Eye Res 1993;56:513-9
467. Yamaguchi K, Gaur VP, Young RW, Sweatt AJ. Cellular retinoic acid-binding protein in rat lacrimal gland. Invest Ophthalmol Vis Sci 1991;32:3273-6
468. Ubels JL, Dennis MH, Rigatti BW, et al. Nuclear retinoic acid receptors in the lacrimal gland. Curr Eye Res 1995;14:1055-62
469. Ubels JL, Osgood TB. 13-cis retinoyl-β-glucuronide in lacrimal gland fluid of rabbits treated with 13-cis retinoic acid. J Ocul Pharmacol 1990;6:321-7
470. Rismondo V, Ubels JL. Isotretinoin in lacrimal gland fluid and tears. Arch Ophthalmol 1987;105:416-20
471. Ubels JL, Sulahian TH, Viel MD. The lacrimal gland expresses nuclear retinoid X receptors. Curr Eye Res 1997;16:511-5
472. Ubels JL, Dennis M, Lantz W. The influence of retinoic acid on growth and morphology of rat exorbital lacrimal gland acinar cells in culture. Curr Eye Res 1994;13:441-9
473. Saarloos MN, Husa MR, Jackson RS 2nd, Ubels JL. Intermediate filament, laminin and integrin expression in lacrimal gland acinar cells: comparison of an immortalized cell line to primary cells, and their response to retinoic acid. Curr Eye Res 1999;19:439-49
474. Rismondo V, Ubels JL, Osgood TB. Tear secretion and lacrimal gland function of rabbits treated with isotretinoin. J Am Acad Dermatol 1988;19:280-5
475. Martinazzi M, Baroni C. Controllo ormonale delle ghiandola lacrimale extraorbitale nel topo con nanismo ipofisario. Folia Endocrinol 1963;16:123-32
476. Jahn R, Padel U, Porsch PH, Soling HD. Adrenocorticotrophic hormone and α-melanocyte stimulating hormone induce secretion and protein phosphorylation in the rat lacrimal gland by activation of a cAMP-dependent pathway. Eur J Biochem 1982;126:623-9
477. Leiba H, Garty NB, Schmidt-Sole J, et al. The melanocortin receptor in the rat lacrimal gland: a model system for the study of MSH (melanocyte stimulating hormone) as a potential neurotransmitter. Eur J Pharmacol 1990;181:71-82
478. Cripps MM, Bromberg BB, Patchen-Moor K, Welch MH. Adrenocorticotropic hormone stimulation of lacrimal peroxidase secretion. Exp Eye Res 1987;45:673-83
479. Entwistle ML, Hann LE, Sullivan DA, Tatro JB. Characterization of functional melanotropin receptors in lacrimal glands of the rat. Peptides 1990;11:477-83
480. Martinazzi M. Effetti dell'ipofisectomia sulla ghiandola lacrimale extraorbitale del ratto. Folia Endocrinol 1962;150:120-9
481. Minami A, Kamel T. Sur la glande lacrymale extérieure chez le rat et ses modifications aprés hypophysectomie. Compt rend Séanc Soc Biol 1959;153:269-73
482. Wegelius O, Friman C. Two different pituitary-controlled sulphation mechanisms in the rat. Acta Med Scand Suppl 1964;suppl 412:221-8
483. Pochin EE. The mechanism of experimental exophthalmos caused by pituitary extracts. Ciba Foundation Colloquia on Endocrinology 1952;4:316-26
484. Ebling FJ, Ebling E, Randall V, Skinner J. The synergistic action of α-melanocyte stimulating hormone and testosterone on the sebaceous, prostate, preputial, harderian and lachrymal glands, seminal vesicles and brown adipose tissue in the hypophysectomized-castrated rat. J Endocrinol 1975;66:407-12
485. McClellan KA, Robertson FG, Kindblom J, et al. Investigation of the role of prolactin in the development and function of the lacrimal and harderian glands using genetically modified mice. Invest Ophthalmol Vis Sci 2001;42:23-30
486. Casbon AJ, Warren DW, Mircheff AK. Prolactin inhibits carbachol-dependent secretion by lacrimal acinar cells in vitro. Adv Exp Med Biol 2002;506(Pt A):231-5
487. Schechter J, Carey J, Wallace M, Wood R. Distribution of growth factors and immune cells are altered in the lacrimal gland during pregnancy and lactation. Exp Eye Res 2000;71:129-42
488. Mircheff AK, Warren DW, Wood RL, et al. Prolactin localization, binding, and effects on peroxidase release in rat exorbital lacrimal gland. Invest Ophthalmol Vis Sci 1992;33:641-50
489. Frey WH, Nelson JD, Frick ML, Elde RP. Prolactin immunoreactivity in human tears and lacrimal gland: Possible implications for tear production, in Holly FJ (ed). The preocular tear film in health, disease and contact lens wear. Lubbock, TX, Dry Eye Institute, 1986, pp 798-807
490. Wood RL, Park K-H, Gierow JP, Mircheff AK. Immunogold localization of prolactin in acinar cells of lacrimal gland. Adv Exp Med Biol 1994;350:75-7
491. Markoff E, Lee DW, Fellows JL, et al. Human lacrimal glands synthesize and release prolactin (abstract). Endocrinology 1995;152(suppl):440A
492. Zhang J, Whang G, Gierow J, et al. Prolactin receptors are present in rabbit lacrimal gland (abstract). Invest Ophthalmol Vis Sci 1995;36(suppl):S991
493. Wood RL, Zhang J, Huang ZM, et al. Prolactin and prolactin receptors in the lacrimal gland. Exp Eye Res 1999;69:213-26
494. Warren DW, Platler BW, Azzarolo AM, et al. Pilocarpine stimulates prolactin secretion by rabbit lacrimal glands (abstract). Invest Ophthalmol Vis Sci 1995;36(suppl):S651
495. Azzarolo AM, Kaswan RL, Huang ZM, et al. Is lacrimal gland prolactin content regulated? (abstract). Invest Ophthalmol Vis Sci 1995;36(suppl):S651
496. Narukawa S, Kanzaki H, Inoue T, et al. Androgens induce prolactin production by human endometrial stromal cells in vitro. J Clin Endocrinol Metab 1994;78:165-8
497. Nevalainen MT, Martikainen P, Valve EM, et al. Prolactin regulation of rat and human prostate (abstract), in Abstracts of the 12th International Symposium of the Journal of Steroid Biochemistry & Molecular Biology (Berlin, Germany) 1995;53P.
498. Reiter E, Bonnet P, Sente B, et al. Growth hormone and prolactin stimulate androgen receptor, insulin-like growth factor-I (IGF-I) and IGF-I receptor levels in the prostate of immature rats. Mol Cell Endocrinol 1992;88:77-87
499. McBlain WA, Hoffman RA, Buzzell GR. Androgen receptor in the harderian glands of the golden hamster: characterization and the effects of androgen deprivation, the pituitary, and gender. J Exp Zoology 1994;268:442-51
500. Reber PM. Prolactin and immunomodulation. Am J Med 1993;95:637-44
501. Wilder RL. Adrenal and gonadal steroid hormone deficiency in the pathogenesis of rheumatoid arthritis. J Rheumatol 1996;44(suppl):10-2
502. Ormandy CJ, Clarke CL, Kelly PA, Sutherland RL. Androgen regulation of prolactin-receptor gene expression in MCF-7 and MDA-MB-453 human breast cancer cells. Int J Cancer 1992;50:777-82
503. Mathers WD, Stovall D, Lane JA, et al. Menopause and tear function: the influence of prolactin and sex hormones on human tear production. Cornea 1998;17:353-8
504. McMurray R, Keisler D, Kanuckel K, et al. Prolactin influences autoimmune disease activity in the female B/W mouse. J Immunol 1991;147:3780-7
505. Tatro JB, Entwistle ML. Heterogeneity of brain melanocortin receptors suggested by differential ligand binding in situ. Brain Res 1994;635:148-58
506. Akbulut S, Byersdorfer CA, Larsen CP, et al. Expression of the melanocortin 5 receptor on rat lymphocytes. Biochem Biophys Res Commun 2001;281:1086-92
507. Chen W, Kelly MA, Opitz-Araya X, et al. Exocrine gland dysfunction in MC5-R-deficient mice: evidence for coordinated regulation of exocrine gland function by melanocortin peptides. Cell 1997;91:789-98
508. Salomon Y, Zohar M, Dejordy JO, et al. Signaling mechanisms controlled by melanocortins in melanoma, lacrimal, and brain astroglial cells. Ann N Y Acad Sci 1993;680:364-80
509. Trousdale MD, Stevenson D, Zhu Z, et al. Effect of anti-inflammatory cytokines on the activation of lymphocytes by lacrimal gland acinar cells in an autologous mixed cell reaction. Adv Exp Med Biol 2002;506(Pt B):789-94
510. Khong PL, Peh WC, Low LC, Leong LL. Variant of the Triple A syndrome. Australasian Radiol 1994;38:222-4
511. Heinrichs C, Tsigos C, Deschepper J, et al. Familial adrenocorticotropin unresponsiveness associated with alacrima and achalasia: biochemical and molecular studies in two siblings with clinical heterogeneity. Eur J Pediatr 1995;154:191-6
512. Tsigos C, Arai K, Latronico AC, et al. A novel mutation of the adrenocorticotropin receptor (ACTH-R) gene in a family with the syndrome of isolated glucocorticoid deficiency, but no ACTH-R abnormalities in two families with the triple A syndrome. J Clin Endocrinol Metab 1995;80:2186-9
513. Chavez M, Moreno C, Perez A, et al. Allgrove syndrome (acalasia-alacrima-insuficiencia adrenal): Report of a case. Rev Gastroenterol Peru 1996;16:153-7
514. Varkonyi A, Julesz J, Szuts P, et al. [Simultaneous occurrence of selective ACTH deficiency, achalasia, alacrimia and hyperlipoproteinemia.] Orv Hetil 1990;131:2763-6
515. Dugardeyn C, Anooshiravani M, Christophe C, et al. Achalasia-alacrima-ACTH insensitivity syndrome (Triple-A-syndrome). J Belge Radiol 1993;76(3):167-8
516. Huebner A, Yoon SJ, Ozkinay F, et al, Triple A syndrome - clinical aspects and molecular genetics. Endocr Res 2000;26:751-9
517. Tristante G, Cordonnier M, Louryan S, et al. The eye and acromegaly: apropos of a case of ptosis. Bull Soc Belge Ophtalmol 1992;243:11-6
518. Djeridane Y. Immunohistochemical evidence for the presence of vasopressin in the rat harderian gland, retina and lacrimal gland. Exp Eye Res 1994;59:117
519. Kahan IL, Varsanyi-Nagy M, Toth M, Nadrai A. The possible role of tear fluid thyroxine in keratoconus development. Exp Eye Res 1990;50:339-43
520. Markitziu A, Lustmann J, Uzieli B, et al. Salivary and lacrimal gland involvement in a patient who had undergone a thyroidectomy and was treated with radioiodine for thyroid cancer. Oral Surg Oral Med Oral Pathol 1993;75:318-22
521. Crowe JP, Christensen E, Butler J, et al. Primary biliary cirrhosis: the prevalence of hypothyroidism and its relationship to thyroid autoantibodies and sicca syndrome. Gastroenterology 1980;78:1437-41
522. Kiljanski J, Nebes V, Wall JR. Significance of tissue specific and tissue non specific autoimmune reactions of Graves' disease. Clin Exp Rheumatol 1996;14 Suppl 15:S69-76
523. Ramos-Remus C, Suarez-Almazor M, Russell AS. Low tear production in patients with diabetes mellitus is not due to Sjogren's syndrome. Clin Exp Rheumatol 1994;12:375-80
524. Goebbels M. Tear secretion and tear film function in insulin dependent diabetics. Br J Ophthalmol 2000;84:19-21
525. Stolwijk TR, Kuizenga A, van Haeringen NJ, et al. Analysis of tear fluid proteins in insulin-dependent diabetes mellitus. Acta Ophthalmologica 1994;72:357-62
526. Gause I, Isaksson O, Lindahl A, Eden S. Effect of insulin treatment of hypophysectomized rats on adipose tissue responsiveness to insulin and growth hormone. Endocrinology 1985;116:945-51
527. Heinze E, Kleine, W, Voigt KH. Insulin release in rats 1 and 5 days after hypophyectomy. Horm Res 1981;14:243
528. Van Lan V, Yamaguchi N, Garcia MJ, et al. Effect of hypophysectomy and adrenalectomy on glucagon and insulin concentrations. Endocrinology 1974;94:671-5
529. Rocha EM, de M Lima MH, Carvalho CR, et al. Characterization of the insulin-signaling pathway in lacrimal and salivary glands of rats. Curr Eye Res 2000;21:833-42
530. Dartt DA, Shulman M, Gray KL, et al. Stimulation of rabbit lacrimal gland secretion with biologically active peptides. Am J Physiol 1988;254:G300-6
531. Huffman L, Michalkiewicz M, Pietrzyk Z, Hedge GA. Helodermin, but not cholecystokinin, somatostatin, or thyrotropin releasing hormone, acutely increases thyroid blood flow in the rat. Regul Pept 1990;15;31:101-14
532. Perra MT, Lantini MS, Serra A, et al. Human meibomian glands: a histochemical study for androgen metabolic enzymes. Invest Ophthalmol Vis Sci 1990;31:771-5
533. Steagall RJ, Yamagami H, Wickham LA, Sullivan DA. Androgen control of gene expression in the rabbit meibomian gland. Adv Exp Med Biol 2002;506:465-76
534. Cermak JM, Krenzer KL, Sullivan RM, et al. Is complete androgen insensitivity syndrome associated with alterations in the meibomian gland and ocular surface? Cornea 2003;30:2413-9
535. Sullivan BD, Evans JE, Cermak JM, et al. Complete androgen insensitivity syndrome: effect on human meibomian gland secretions. Arch Ophthalmol 2002;120:1689-99
536. Sullivan BD, Dana MR, Sullivan DA. Influence of aging on the polar and neutral lipid profiles in human mebiomian gland secretions (abstract). Invest Ophthalmol Vis Sci 2001;42(suppl):S39
537. Wirth H, Gloor M, Kimmel W. Influence of cyproterone acetate and estradiol on cell kinetics in the sebaceous gland of the golden hamster ear. Arch Dermatol Res 1980;268:277-81
538. Thody AJ, Shuster S. Control and function of sebaceous glands. Physiol Rev 1989;69:383-416
539. Pochi PE, Strauss JS. Endocrinologic control of the development and activity of the human sebaceous gland. J Invest Dermatol 1974;62:191-201
540. Schafer G, Krause W. The effect of estradiol on the sebaceous gland of the hamster ear and its antagonism by tamoxifen. Arch Dermatol Res 1985;277:230-4
541. Sweeney TM, Szarnicki RJ, Strauss JS, Pochi PE. The effect of estrogen and androgen on the sebaceous gland turnover time. J Invest Dermatol 1969;53:8-10
542. Strauss JS, Kligman AM, Pochi PE. The effect of androgens and estrogens on human sebaceous glands. J Invest Dermatol 1962;39:139-55
543. Sansone-Bazzano G, Reisner RM, Bazzano G. A possible mechanism of action of estrogen at the cellular level in a model sebaceous gland. J Invest Dermatol 1972;59:299-304
544. Pochi PE. Acne: endocrinologic aspects. Cutis 1982;30:212-22
545. Saihan EM, Burton JL. Sebaceous gland suppression in female acne patients by combined glucocorticoid-oestrogen therapy. Br J Dermatol 1980;103:139-42
546. Pochi PE, Strauss JS. Sebaceous gland inhibition from combined glucocorticoid-estrogen treatment. Arch Dermatol 1976;112:1108-9
547. Stevenson D, Tauber J, Reis BL. Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. The Cyclosporin A Phase 2 Study Group. Ophthalmology 2000;107:967-74
548. Sall K, Stevenson OD, Mundorf TK, Reis BL. Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group. Ophthalmology 2000;107:631-9; erratum in Ophthalmology 2000;107:1220
549. Jung-Testas I, Lebeau MC, Catelli MG, Baulieu EE. Cyclosporin A promotes nuclear transfer of a cytoplasmic progesterone receptor mutant. CR Acad Sci III 1995;318:873-8
550. Ratajczak T, Mark PJ, Martin RL, Minchin RF. Cyclosporin A potentiates estradiol-induced expression of the cathepsin D gene in MCF7 breast cancer cells. Biochem Biophys Res Commun 1996;220:208-12
551. Sulli A, Pizzorni C, Scotto-Busato R, et al. Androgenizing effects of cyclosporin A in rheumatoid arthritis. Ann N Y Acad Sci 1999;876:391-6
552. Cutolo M, Giusti M, Villaggio B, et al. Testosterone metabolism and cyclosporin A treatment in rheumatoid arthritis. Br J Rheumatol 36:433-9
553. Kaku K. Experimental studies on the function of the lacrimal gland. II. Report on histological findings of various endocrine glands in lacrimotectomized rats. Acta Soc Ophthalmol Jpn 1955;59:975-9